US20180289866A1 - Nanoparticles and preparation method thereof - Google Patents

Nanoparticles and preparation method thereof Download PDF

Info

Publication number
US20180289866A1
US20180289866A1 US15/763,625 US201615763625A US2018289866A1 US 20180289866 A1 US20180289866 A1 US 20180289866A1 US 201615763625 A US201615763625 A US 201615763625A US 2018289866 A1 US2018289866 A1 US 2018289866A1
Authority
US
United States
Prior art keywords
nanoparticle
magnetic
surface modifier
nanoparticles
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/763,625
Inventor
Yinghao SUN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Clinical Engine Technology Development Co Ltd
Shanghai Clinical Engine Technology Development Cl
Original Assignee
Shanghai Clinical Engine Technology Development Co Ltd
Shanghai Clinical Engine Technology Development Cl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Clinical Engine Technology Development Co Ltd, Shanghai Clinical Engine Technology Development Cl filed Critical Shanghai Clinical Engine Technology Development Co Ltd
Assigned to SHANGHAI CLINICAL ENGINE TECHNOLOGY DEVELOPMENT CO., LTD. reassignment SHANGHAI CLINICAL ENGINE TECHNOLOGY DEVELOPMENT CO., LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SUN, Yinghao
Publication of US20180289866A1 publication Critical patent/US20180289866A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/028Other inorganic materials not covered by A61L31/022 - A61L31/026
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00163Optical arrangements
    • A61B1/00165Optical arrangements with light-conductive means, e.g. fibre optics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/00163Optical arrangements
    • A61B1/00195Optical arrangements with eyepieces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/05Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances characterised by the image sensor, e.g. camera, being in the distal end portion
    • A61B1/051Details of CCD assembly
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/225Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/50Instruments, other than pincettes or toothpicks, for removing foreign bodies from the human body
    • A61B17/52Magnets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B34/00Computer-aided surgery; Manipulators or robots specially adapted for use in surgery
    • A61B34/70Manipulators specially adapted for use in surgery
    • A61B34/73Manipulators for magnetic surgery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/02Inorganic materials
    • A61L31/022Metals or alloys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/048Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/07Metallic powder characterised by particles having a nanoscale microstructure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B22CASTING; POWDER METALLURGY
    • B22FWORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
    • B22F1/00Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
    • B22F1/10Metallic powder containing lubricating or binding agents; Metallic powder containing organic material
    • B22F1/102Metallic powder coated with organic material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00477Coupling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00526Methods of manufacturing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00681Aspects not otherwise provided for
    • A61B2017/00734Aspects not otherwise provided for battery operated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00876Material properties magnetic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22082Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
    • A61B2017/22087Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance photodynamic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Definitions

  • the present invention relates to nanoparticles and methods of making the same. Further, the present invention also relates to a stone removing device containing nanoparticles and its application.
  • Urinary calculi/stone have an incidence as high as 5%-10%, and can be found in any part of kidney, bladder, ureter and urethra, in which stones in kidney and ureter are common. It is found in clinical observation that calcium-containing stones are the most common types of urinary stones, that is, about 70% to 80% of all urinary stones. At present, there are only a few cases of calcium-containing stones which pathological causes have been clearly revealed, while the causes for most of calcium-containing stones are not yet clear. According to chemical composition, stones can be divided into four categories: calcium-containing stones, infection induced stones, uric acid stones and cystine stones.
  • Calcium-containing stones can be divided into following types: simple calcium oxalate, calcium oxalate with calcium phosphate, calcium oxalate with a small amount of uric acid; the main components of infection induced stones are ammonium magnesium phosphate and hydroxyapatite; uric acid stones can be divided into following types: uric acid, uric acid amine, or those containing a small amount of calcium oxalate in addition to the above ingredients; cystine stones can be divided into following types: simple cystine, or cystine with a small amount of calcium oxalate.
  • Soft/hard ureteroscopic lithotripsy is performed through natural channel of the human body, has the advantages of small trauma and definite lithothriptic effect, and is currently the main treatment means for most of ureteral stones and kidney stones.
  • the current soft/hard ureteroscopic lithotripsy also has some deficiencies: 1) upper ureteral stones and fragments of stones in ureter may be easily brought back to kidney by the infused water or the recoil force of lithotripsy tools; 2) there is lack of a fast, safe and effective method to take out residual debris of stones in ureteral lumen and kidney calices.
  • JP2009536081 A, DE19904569A1, WO2004056275A1, WO2011123274A1 are designed with a net bag) are the most commonly used stone interception and removal tools, which cross over stone and then are opened to form a net so as to prevent the upward drift of stone debris, and at the same time, the stone baskets are also used as stone removal tools to net and take out small stone debris.
  • the amount of stone removed by the stone basket every time is limited, so that multiple feeds of ureteroscope are needed, while repeated injection of water and feeds of ureteroscope would increase the risk of residual debris drift; in addition, the stone basket can not completely seal the ureteral lumen, and there are still a chance that stones escape from the net; moreover, the edges of stones in stone basket may be easily squeezed out from basket holes, and thus may easily scratch the ureter wall when the stones are dragged and removed, thereby causing complications in severe cases.
  • CN105283140A describes a kit of a cross-linked gel for encapsulating urethral stones and/or debris of urethral stones.
  • a gel-containing magnetic reagent (mock) is added to an aqueous solution containing stones, the cationic polymer is dispersed substantially in the form of dissolving in a solvent rather than aggregates to the periphery of stones due to the principle of similar compatibility, which is not sufficient to magnetize stones and remove stones.
  • a first object of the present invention is to provide a nanoparticle that can be used safely and efficiently to remove a stone located at a position such as kidney, ureter and so on in an urinary system, and the nanoparticle has excellent dispersibility.
  • a second object of the present invention is to provide a method for preparing the nanoparticle with different morphological structures.
  • a nanoparticle comprising a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by attaching a surface modifier monomer to the nanoparticle core with an initiator and/or a crosslinking agent.
  • the nanoparticle comprises: a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent; wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the weight percentage of the shell is 0.5-45% (excluding end points), preferably 1-40%, more preferably 2-40%, further more preferably 1-15% or 2-15%, most preferably 1%, 2%, 15% or 40%, with regard to the weight of the nanoparticles.
  • the nanoparticle comprises: a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent, wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the method for preparing the magnetic nanoparticle core is a co-precipitation method, wherein a solution of the magnetic material and a catalyst are added in the manner of electronic pump-assisted continuous dropping.
  • the nanoparticle comprises: a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent; wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the method for preparing the magnetic nanoparticle core is a co-precipitation method, wherein the surface modifier monomer is added in the manner of electronic pump-assisted continuous dropping.
  • the nanoparticle surrounds a stone through physical adsorption, chemical bonding, and photosensitive, thermosensitive, and pH-sensitive crosslinking; specifically, the mutual forces for binding and surrounding between the nanoparticles and the stone include: van der Waal's force that form an interacting surrounding, hydrophobic interaction, adsorption and surface deposition; covalent bonds formed between carboxyl-stone, including hydrogen bonds, ester bonds, amide bonds, and other covalent bonds; interacting physical entanglement and chemical crosslinking between chains.
  • the nanoparticle core has a diameter of 2-50 nm, and a weight percentage of 30-95% with regard to the whole weight of the nanoparticle
  • the magnetic material constituting the core includes a compound of Fe 3+ , Fe 2+ , Mn 2+ or Ni 2+ , or a metal element selected from iron, nickel, copper, cobalt, platinum, gold, europium, gadolinium, dysprosium, terbium, or a composite or oxide of the aforementioned metals, or any one of the above items or a combination of two or more of the above items, preferably one of or a combination of any two of Fe 3+ , Fe 2+ , Mn 2+ or Ni 2+ , more preferably Fe 3+ and Fe 2+ in a ratio of 15% to 85%, preferably 1:2.5 to 1.5:1.
  • the method for preparing the nanoparticle used in the present invention can well control the size and dimension of the magnetic nanoparticle core; especially, in comparison with the nanoparticles prepared by other methods, among the parameters of the nanoparticle obtained in the present invention that relates to the biomedical application, the dispersibility of the nanoparticle is very good and less than 1.1.
  • the surface modifier includes a hydrophilic surface modifier with function response, a hydrophobic surface modifier with function response, a photosensitive surface modifier with function response, a thermosensitive surface modifier with function response or a pH sensitive surface modifier with function response
  • the hydrophilic surface modifier includes acrylic acid, methacrylic acid, isobutyl acrylamide or poly N-substituted isopropylacrylamide
  • the hydrophobic surface modifier includes olefins, preferably polystyrene, polyethylene or oleic acid
  • the photosensitive surface modifier is selected from the group consisting of azos and quinolines and benzophenones (PVBP), preferably vinyl benzophenone
  • the thermosensitive surface modifier is selected from the group consisting of amphiphilic polymers with an amide bond, preferably polyacrylamide or poly N-substituted isopropylacrylamide
  • the pH-sensitive surface modifier is selected from the group consisting of polymers with a carboxyl group and a qua
  • the crosslinking agent includes 3-(methacryloyloxy)propyltriethoxysilane, divinylbenzene, diisocyanate or N,N-methylenebisacrylamide, and the initiator includes 3-chloropropionic acid, CuCl, 4,4′-dinonyl-2,2-bipyridine or potassium persulfate.
  • the second aspect of the invention provides a method of preparing the nanoparticle, including the steps of: a) preparing the nanoparticle core using the magnetic material; and b) forming the nanoparticle shell by in-situ linking the surface modifier monomer to the nanoparticle core by the initiator and/or crosslinking agent.
  • in-situ means that the surface modifier is directly attached to the surface of the nanoparticle core.
  • the resulting modified nanoparticle has a size between 50 nm and 5000 nm, which varies according to different conditions.
  • the nanoparticle core is composed of Fe 3 O 4 , MnFe 2 O 4 , ⁇ -Fe 2 O 3 , or other nanoscale-sized ferrite particles, and these ferrite particles are prepared by the following steps:
  • the oxygen-containing metal salt is FeCl 3 .6H 2 O and FeCl? 2 .4H 2 O, which are dissolved in water in a molar ratio of 15% to 85%, preferably 1:2.5 to 1.5:1, wherein the catalyst is aqueous ammonia.
  • Fe 3 O 4 nanoparticles can be obtained by following the above steps.
  • the step b) includes dispersing the prepared nanoparticles in an aqueous solution, adding with an xylene solution of 3-chloropropionic acid, polystyrene, CuCl and 4,4′-dinonyl-2,2-bipyridine, wherein the molar ratio between the solution of iron particles and the reaction solution is 1:1; reacting the mixture for 15-30 hours, preferably 24 hours, at 130° C. under continuous agitation; and collecting the nanoparticles with a magnet, washing repeatedly with toluene to obtain hydrophobic polystyrene-surrounded magnetic iron oxide nanoparticles.
  • the step b) includes dissolving and dispersing the resulting nanoparticle core into xylene, adding with a silane coupling agent, wherein the silane coupling agent, wherein the nanoparticles, xylene and silane coupling agent are added in a ratio of 95:5; reacting under the protection of nitrogen atmosphere at 20-100° C., preferably at 80° C., for 2-5 hours, preferably for 3 hours; washing with an alcoholic solvent (preferably absolute ethanol) and drying for 12 hours, dispersing in an aqueous solution under ultrasonic condition, adding with potassium persulfate; reacting under nitrogen protection, at 40-80° C.
  • a silane coupling agent wherein the silane coupling agent, wherein the nanoparticles, xylene and silane coupling agent are added in a ratio of 95:5
  • reacting under the protection of nitrogen atmosphere at 20-100° C., preferably at 80° C., for 2-5 hours, preferably for 3 hours
  • the above step b includes: dissolving and dispersing Fe 3 O 4 nanoparticles into xylene, and adding with a silane coupling agent, wherein the silane coupling agent (the ratio of the Fe 3 O 4 nanoparticles and the silane coupling agent as added is 95:5); reacting under protection of nitrogen atmosphere at 80° C. for 2-5 hours, preferably for 3 hours; washing with an alcoholic solvent (preferably absolute ethanol) and drying for 12 hours, dispersing in an aqueous solution under ultrasonic condition, adding with potassium persulfate; reacting under nitrogen protection at 40-80° C.
  • a silane coupling agent the ratio of the Fe 3 O 4 nanoparticles and the silane coupling agent as added is 95:5
  • an alcoholic solvent preferably absolute ethanol
  • a photosensitive monomer such as vinyl benzophenone, a thermosensitive monomer such as N-isopropylacrylamide, or a pH-sensitive monomer such as dimethylaminopropyl methacrylate, etc. (or a blended monomer of acrylic acid and styrene), reacting continuously for 1 hour at 40-80° C., preferably at 70° C.; and separating with a magnet, washing and drying to obtain the photosensitive, thermosensitiveor pH sensitive functional monomer-modified magnetic nanoparticles, respectively.
  • a photosensitive monomer such as vinyl benzophenone, a thermosensitive monomer such as N-isopropylacrylamide, or a pH-sensitive monomer such as dimethylaminopropyl methacrylate, etc.
  • the photosensitive monomer modification based on the hydrophilic surface modification includes: dissolving and dispersing the polyacrylic acid-modified magnetic nanoparticles in an alcoholic solvent, dispersing for 5-30 minutes under ultrasonic condition, then adding an initiator and a photosensitive monomer polyvinylbenzophenone, refluxing and reacting at agitation and 130° C. for 24 hours under condition that oxygen is kept out to prepare the photosensitive monomer-modified magnetic nanoparticles.
  • the method for dropping aqueous ammonia is performed in a continuous and dropwise manner with assistance of an electronic pump at a speed of 20-100 drops/minute, preferably 40-60 drops/minute; and when the magnetic material is an element material, the liquid monomer is added in a dropwise and continuous manner with assistance of an electronic pump, and the reaction is carried out under agitation with a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
  • the particle size, distribution and morphology (such as shape of sphere, rod, diamond, etc.) of the obtained magnetic nanoparticle core can be relatively easily controlled under the synthetic methods and preparation conditions as we designed above.
  • the surface-modified magnetic nanoparticles prepared by the above method have particle size and distribution superior to those of magnetic nanoparticles obtained by conventional preparation methods.
  • the dispersibility index (PD.I.) of the obtained nanoparticles is basically close to 1.0, which clearly shows that the particle size distribution of the obtained particles is narrow. This is very important because, for in vivo biomedical applications, the size and dispersion of nanoparticles determine the breadth of their medical applications.
  • the PD.I described herein for describing the dispersibility of nanoparticles is defined as follows:
  • Rh hydrodynamic radius of particle
  • the nanoparticle core and the surface-modified magnetic nanoparticle have distribution PD.I. as shown in the following table:
  • Magnetic nanoparticle core After surface modification Diameter/nm 40-50 80-100 PD.I./a.u. 0.005 0.0055
  • a device for removal of stone which can be used in the urinary system and consists of a magnetic nanoparticle in combination with a stone-removal magnetic probe rod system.
  • the device for removal of stone comprises the above-mentioned nanoparticles of the present invention and an auxiliary stone-removal magnetic probe rod system.
  • the device for removal of stone can be used for removing a stone in urinary system such as kidney stone, ureteral stone and bladder stone, etc., as well as removing a stone in human biliary system and a stone-like particle in other organs.
  • the stone-removal magnetic probe rod system comprises a handle, a flexible rod, a magnetic field source, a magnetically permeable material section, etc.
  • the handle may be provided with an AC or DC power supply, a power switch, a DC battery compartment and an AC plug
  • the flexible rod is made of a polymer material including, for example, PU, TPU, PE, PVC, NYLON, PEBAX and silicone rubber and the modified materials of the above materials
  • the magnetic field source made of a permanent magnet or electromagnet can be embedded in the flexible rod, and optionally a high performance magnetically permeable material is connected to the magnetic field source to form the flexible probe rod with different configurations, for example, the permanent magnet is placed in the middle or back end of the flexible rod, and the magnetically permeable material is placed in the distal end of the flexible rod, so that such configuration is more conducive to the treatment of renal stones under ureteroscope to avoid the situation that the distal end of the flexible rod becomes rigid due to the rigid structure of the permanent magnet or
  • an article comprising the nanoparticle of the present invention, in which the nanoparticle is prepared in the form of a solution or powder.
  • the invention provides a novel preparation process for synthesizing hydrophilic, hydrophobic, thermosensitive and pH-sensitive as well as photosensitive magnetic nanoparticles, which has the advantages of simple preparation process, good repeatability and convenient application.
  • the stones are surrounded; and the thermosensitive and pH-sensitive nanoparticles can surround stones through physically surrounding action in ureter; thereby, small stone remaining in body can be removed quickly without damage from the body under the action of an externally applied magnetic field, that is, the stone can be drawn and moved without injuring ureteral wall, and the nanoparticles are placed conveniently without shift.
  • FIG. 1 shows the transmission electron microscope (TEM) images and the particle size distribution diagrams under dynamic light scattering for the cores with different morphologies obtained in Example 1 of the present invention.
  • TEM transmission electron microscope
  • FIG. 2 shows the particle size distribution diagram under dynamic light scattering for the monomer-modified nanoparticles obtained in Example 4 of the present invention; and TEM images of the monomer-modified nanoparticles obtained in Example 3 of the present invention.
  • FIG. 3 shows the hysteresis curves of the monomer-modified nanoparticle cores with different Fe 3+ /Fe 2+ ratios in the synthesis of the nanoparticles obtained in Example 3 of the present invention.
  • FIG. 4 shows the graphs of stone separation for the photosensitive monomer-modified nanoparticle cores obtained in Example 4 of the present invention, and the graphs of separation performance for the nanoparticle cores synthesized with different Fe 3+ /Fe 2+ ratios and modified with functional monomer.
  • FIG. 5 shows a graph of biocompatibility to 293t cells for the functional magnetic nanoparticles obtained in Example 4 of the present invention.
  • FIG. 6 shows a graph of stone separation with in vitro assistance for the nanoparticles obtained in Example 6 of the present invention.
  • FIG. 7 shows a graph of safety evaluation in body of animals for the nanoparticles of the present invention.
  • FIG. 8 shows an overall schematic diagram of the magnetic probe rod system for assisting stone removal in the present invention.
  • FIG. 9 shows a schematic view of the handle portion of the magnetic probe rod system for assisting stone removal in the present invention.
  • FIG. 10 shows a schematic view of the magnetic probe rod system with an AC power supply for assisting stone removal according to the present invention.
  • FIG. 11 shows a schematic view of the internal structure of the magnetic probe rod system using an electromagnet as magnetic field source according to the present invention.
  • FIG. 12 shows a schematic view of the magnetic probe rod system of the present invention which uses an electromagnet as magnetic field source and a magnetically permeable material section at distal end.
  • FIG. 13 shows a schematic view of the magnetic probe rod system of the present invention which uses a permanent magnet as magnetic field source and a magnetically permeable material section at distal end.
  • FIG. 14 shows a schematic view of the magnetic probe rod system of the present invention which uses a permanent magnet as magnetic field source and has not a magnetically permeable material section at distal end.
  • FIG. 15S shows a diagram of the principle of interaction between magnetic particles and stones.
  • FIG. 16 shows a diagram of agitation of the reaction system in steps 2-4) of the method for preparing the nanoparticles of the present invention, which uses a magnetic stirrer at a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
  • FIG. 17 shows a diagram of the steps 1-4) of the method for preparing the nanoparticles according to the present invention, in which aqueous ammonia and liquid monomer are added dropwise continuously and uniformly by an electronic pump at a rate of 20-100 drops/minute, preferably 40-60 drops/minute.
  • FIG. 18 shows the effect of addition mode of the surface modifier monomer on the particle dispersibility.
  • FIG. 19 and FIG. 20 show TEM images of the particles after continuous addition and dropping.
  • FIG. 21 shows the effect of the weight percentage of the nanoparticle shell with regard to the nanoparticle on the dispersibility of the nanoparticle.
  • a magnetic nanoparticle with good dispersibility capable of safely and efficiently removing stones in urinary system.
  • the present invention provides a functional magnetic nanoparticle, comprising: hydrophilic, hydrophobic, photosensitive, thermosensitive, pH-sensitive magnetic nanoparticles, which morphology can be spherical, rod-shaped and the like, which structure can be of core-shell structure consisting of a magnetic core and a monomer modifier such as hydrophilic, hydrophobic, temperature sensitive, pH-sensitive or photosensitive surface modifiers as well as a small amount of initiator; in which the hydrophilic surface modifier forms a hydrophilic shell by polymerization to surround the magnetic nanoparticle core, including the hydrophilic materials with positive charges, negative charges and electricity neutrality; the hydrophobic surface modification is carried out by a poor water-soluble polymer or inorganic material; the other functional materials such as photosensitive, thermosensitive and pH-sensitive monomer modifiers may be polymerized by a crosslinking agent and embedded in
  • the materials for synthesizing magnetic nanoparticle cores comprise Fe 3+ , Fe 2+ and Mn 2+ , Ni 2+ compounds, as well as metal elements such as iron (Fe), nickel (Ni), copper (Cu), cobalt (Co), platinum (Pt), gold (Au), europium (Eu), gadolinium (Gd), dysprosium (Dy), terbium (Tb), or composites and oxides of the metals, such as Fe 3 O 4 or MnFe 2 O 4 , preferably iron, manganese or their compounds; also preferably, any one of them or any combination of two or more of them may be used; and the core has a size of 2-50 nm.
  • metal elements such as iron (Fe), nickel (Ni), copper (Cu), cobalt (Co), platinum (Pt), gold (Au), europium (Eu), gadolinium (Gd), dysprosium (Dy), terbium (Tb), or composites and oxides of the metals, such
  • the preparation method of the magnetic nanoparticle core includes co-precipitation methods, emulsion methods, redox reaction or high-temperature high-pressure methods.
  • the weight percentage of the magnetic nanoparticle core is 30% to 95% with regard to the total weight of the functional magnetic nanoparticle, taking the synthesis of Fe 3 O 4 as example, the ratio of Fe 3+ to Fe 2+ is 15% to 85%, preferably 1:2.5 to 1.5:1 for Fe 3+ and Fe 2+ .
  • the surface of the magnetic nanoparticle can be subjected to functional modification, such as hydrophilic modification, hydrophobic modification, and modification with photosensitive, thermosensitive and pH-sensitive materials.
  • a hydrophilically modified functional particle wherein the core size is 2-50 nm, the magnetic nano-core has a weight of 30-95% with regard to the total nanoparticle;
  • the hydrophilic surface modifier is a polycationic or an anionic polymer, such as acrylic acid, methacrylic acid and isobutyl acrylamide, etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle.
  • the magnetic core particle is attached on its surface with an initiator such as 3-chloropropionic acid or the like, then a polymer based on acrylic acid, methacrylic acid and isobutyl acrylamide or the like is modified on the particle surface with a crosslinking agent by a chemical reaction, such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the shape of the particle may be spherical, rod-shaped and layered, preferably spherical particles.
  • the crosslinking to agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • a hydrophobically modified functional particle wherein the core has a size of 2-50 nm, the magnetic nano-core is 30-95% by weight with regard to the whole nanoparticle;
  • the hydrophobic surface modifier is an water insoluble monomer, such as olefins, for example, polystyrene and the like, which weight percentage is 2-8% by weight with regard to the whole hydrophobic magnetic nanoparticle.
  • the magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a hydrophobic polymer based on styrenes is modified on the particle surface by a crosslinking agent via a chemical reaction such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the morphology of the particle may be spherical, rod-shaped and layered, preferably spherical particle.
  • the crosslinking agent is 3-(methacryloyloxy) propyl triethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • a photosensitive surface-modified functional particle wherein the core has a size of 2-50 nm, and the magnetic core is 30-95% by weight with regard to the whole nanoparticle;
  • the photosensitive modifier is selected from the group consisting of azos and quinolines as well as benzophenones (PVBP), etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle.
  • the magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a photosensitive polymer based on benzophenone (PVBP) and the like is modified to the surface of the particle by a crosslinking agent via a chemical reaction such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the morphology of the particle may be spherical, rod-shaped and layered, preferably spherical particle.
  • the crosslinking agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • thermosensitive surface-modified functional particle wherein the size of the core is 2-50 nm, and the magnetic nano-core is 30-95% by weight with regard to the whole nanoparticle;
  • the thermosensitive surface modifier is selected from the group consisting of amphiphilic polymers carrying amide bonds, such as polyacrylamide, poly N-substituted isopropylacrylamide, etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle.
  • the magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a thermosensitive polymer such as poly N-substituted isopropylacrylamide is modified to the surface of the particle by a crosslinking agent via a chemical reaction such as radical, ring-opening assembly and atom transfer radical polymerization (ATRP); the shape of the particle may be spherical, rod-shaped and layered, preferably spherical particle.
  • the crosslinking agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • a pH-sensitive surface-modified functional particle wherein the core has a diameter of 2 to 50 nm, the magnetic nano-core is 30 to 95% by weight with regard to the whole nanoparticle;
  • the pH-sensitive surface modifier is selected from the group consisting of polymers carrying carboxyl groups and quaternary ammonium salt groups, such as polyacrylic acid, dimethylaminoethyl ester and dimethylaminopropyl methacrylate, etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle.
  • the magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a pH-sensitive polymer based on dimethylaminoethyl methacrylate and dimethylaminopropyl methacrylate or the like is modified to the surface of the particle by a crosslinking agent via a chemical reaction such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the shape of the particle may be spherical, rod-shaped and layered, preferably spherical particle.
  • the crosslinking agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • an initiator and/or a crosslinking agent are further included.
  • the initiator includes thermal initiators, for example, potassium persulfate, ammonium persulfate and azo type initiators;
  • the crosslinking agent includes 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA), molecular weight is 100,000, and oleic acid, etc.
  • a preparation method for a nanoparticle generally includes two main steps: synthesis of a magnetic nanoparticle core, and various surface modifications based on the magnetic nanoparticle core (hydrophilic, hydrophobic and thermosensitive, photosensitive and pH-sensitive modification). Taking the preparation of magnetic Fe 3 O 4 nanoparticles as an example, the two steps of the preparation method are respectively described in detail.
  • FeCl 3 .6H 2 O and FeCl 2 .4H 2 O in a certain molar ratio are dissolved in 100 mL of water, fed with nitrogen gas to expel oxygen in the solution, added with aqueous ammonia at a room temperature of 20-30° C. to adjust the pH value of 8-12, preferably 10, and kept agitation and reaction for 20-40 minutes; then under a 50-100° C., preferably 70° C. water bath, the reaction is carried out for 20-40 minutes, and then Fe 3 O 4 nanoparticles are obtained by separation with a magnet and drying.
  • preparation methods such as co-precipitation method, thermal decomposition method, hydrothermal synthesis method, microemulsion method (reverse micelle method) and the like.
  • the Fe 3 O 4 nanoparticle core prepared in the step 1) is dispersed into an aqueous solution, added with an initiator 3-chloropropionic acid and pre-treated for 12 hours, then added with an xylene solution of a hydrophobic surface-modifying monomer polystyrene and an active initiator CuCl and 4,4′-dinonyl-2,2-dipyridine (the molar ratio of the iron particle solution and the reaction solution is 1:1), and the mixture solution is reacted under continuous agitation at 130° C. for 15-30 hours, preferably 24 hours; the resulting nanoparticles are collected with a magnet and washed repeatedly with toluene to obtain the hydrophobic polystyrene-surrounded magnetic iron oxide nanoparticles.
  • the reaction time is preferably 18 to 30 hours, preferably 24 hours.
  • the solvent is toluene or xylene in an amount of 1 ⁇ 2 to 1 of the monomer volume, the mass ratio of the surface-modified polystyrene magnetic nanoparticles, the initiator and the monomer is 95:0.5:4.5.
  • the Fe 3 O 4 nanoparticle core obtained in the above step 1) is dissolved and dispersed into xylene, added with a silane coupling agent (the addition ratio of Fe 3 O 4 , nanoparticles and the silane coupling agent is 95:5), and reacted at 80° C. under nitrogen protection for 2-5 hours, preferably 3 hours; then washed with an alcoholic solvent (preferably absolute ethanol) and dried for 12 h, dispersed in an aqueous solution under ultrasonic condition, added with potassium persulfate; reacted under nitrogen protection at 40-80° C. for 10 minutes, then added with acrylic acid and reacted continuously at 40-80° C. for 1 hour, preferably reacted at a reaction temperature of 70° C.; separated by a magnet, washed and dried to obtain polyacrylic acid-modified, hydrophilic surface-modified magnetic nanoparticles.
  • a silane coupling agent the addition ratio of Fe 3 O 4 , nanoparticles and the silane coupling agent is 95:
  • the silane coupling agent is 3-(methacryloyloxy)propyltriethoxysilane (MPS) in an amount of 8 to 16 times the mass of acrylic acid; the solvent is benzene or 2-toluene; potassium persulfate is used as initiator; the reaction time is preferably 20 minutes to 80 minutes.
  • the mass ratio of the surface-modified magnetic Fe 3 O 4 nanoparticles, the potassium persulfate and the acrylic acid monomer is 25-100:1:100.
  • the alcoholic solvent here is methanol, ethanol or butanol, preferably ethanol
  • the reaction temperature is preferably 100° C. to 150° C.
  • the reaction time is preferably 18 hours to 24 hours
  • the mass ratio of the photosensitive monomer-modified magnetic nanoparticles, the potassium sulfate and the vinylbenzophenone monomer is 25-100:1:100.
  • the Fe 3 O 4 nanoparticle core as prepared in the above step 1) is dissolved and dispersed into xylene, added with a silane coupling agent (the addition ratio of the Fe 3 O 4 nanoparticles and the silane coupling agent is 95:5), reacted under nitrogen protection at 80° C. for 2-5 hours, preferably 3 hours, then washed with an alcoholic solvent (preferably absolute ethanol) and dried for 12 hours, dispersed into an aqueous solution under ultrasonic condition, added with potassium persulfate; reacted under nitrogen protection at 40-80° C.
  • a silane coupling agent the addition ratio of the Fe 3 O 4 nanoparticles and the silane coupling agent is 95:5
  • the functionally modified nanoparticles here may also be obtained by a cross-reaction with steps 2.1 and 2.2) and step 3) after pre-modification of the surface of the nanoparticle in the steps 2.1 and 2.2). That is, after the modification of 3-chloropropionic acid in step 2.1 (or the modification of silane coupling agent in step 2.2), the hydrophobic monomer styrene (or hydrophilic monomer acrylic acid) and the functional monomer such as vinyl benzophenone, N-substituted isopropylacrylamide or dimethylaminoethyl methacrylate and the like are added at the same time, and reacted at 40-80° C.
  • the silane coupling agent is 3-(methacryloyloxy)propyltriethoxysilane (MPS) in an amount of 8 to 16 times the mass of acrylic acid; the solvent is benzene or 2-toluele in an amount of 8 to 16 times the mass of acrylic acid; potassium persulfate is used as initiator; the reaction time is preferably 20 minutes to 80 minutes.
  • the mass ratio of the surface-modified magnetic Fe 3 O 4 nanoparticles, the potassium persulfate and the acrylic acid monomer is 25-100:1:100.
  • the alcoholic solvent here is methanol, ethanol or butanol, preferably ethanol
  • the reaction temperature is preferably 100° C. to 150° C.
  • the reaction time is preferably 18 hours to 24 hours.
  • the mass ratio of the functional monomer-modified magnetic nanoparticles, the potassium persulfate and the functional monomer is 25-100:1:100.
  • the Fe 3 O 4 nanoparticles are nanoscale ferroferric oxide particles (Fe 3 O 4 ), MnFe 2 O 4 , nanoscale ferric oxide particles ( ⁇ -Fe 2 O 3 ) or other nanoscale ferrite particles
  • the aqueous ammonia is used as catalyst
  • the reaction pH is preferably 9 to 10
  • the reaction time is preferably 20 to 30 minutes
  • the reaction temperature is between 50-100° C., preferably 70-80° C.
  • the preferred ratio of Fe 3+ :Fe 2+ is 15% to 85%, preferably 1.5:1 to 1:2.5.
  • the nanoparticle core is nanoscale ferroferric oxide particles (Fe 3 O 4 ).
  • Fe 3 O 4 nanoscale ferroferric oxide particles
  • MnFe 2 O 4 nanoscale ferric oxide particles
  • ⁇ -Fe 2 O 3 nanoscale ferric oxide particles
  • the aqueous ammonia is used as catalyst, the reaction pH is preferably 9 to 10, the reaction time is preferably 20-30 minutes, the reaction temperature is between 50-100° C., preferably 70-80° C.
  • the preferred ratio of Fe 3+ :Fe + is 15% to 85%, preferably 1:2.5 to 1.5:1.
  • the agitation in the above reaction system is performed by a magnetic stirrer at a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
  • the aqueous ammonia and the liquid monomer are added dropwise continuously and uniformly by an electronic pump at a rate of 20-100 drops/minute, preferably 40-60 drops/minute.
  • an electronic pump for continuous and uniform dripping, large-scale production can be easily achieved, and the dispersibility and uniformity of nanoparticles can be well controlled.
  • a magnetic probe rod system for assisting the removal of stone in urinary system.
  • the magnetic probe rod system comprises a handle 1 , a flexible rod 2 , a magnetic field source 3 , and an optional magnetically permeable material section 4 (in the present invention, the side of the handle is defined as the proximal end of the instrument, and the end of the magnetic field source is defined as the distal end).
  • a switch 11 can be integrated into the handle 1 , and the magnetic field power supply can be selected from DC battery, and a battery compartment 12 a and a battery cover 13 a are provided accordingly; when an AC power is selected as the magnetic field power supply, an AC power plug 12 b is provided on the handle correspondingly.
  • the magnetic field source 3 is composed of an electromagnet core 32 a and an electromagnetic coil 33 a , and externally provided with a magnetic field source encapsulation membrane 31 a made by biocompatible material; when the magnetic field source 3 is a permanent magnet, the magnetic field source 3 is composed of the permanent magnet 32 b and the magnetic field source encapsulation membrane 31 b on its surface; in order to ensure the accessibility of the present invention in human body, a magnetically permeable material section 4 can be optionally disposed at the distal end of the magnetic field source 3 , that is, when the electromagnet is used as the magnetic field source, the magnetically permeable material section 4 a can be optionally disposed at the distal end of the electromagnet 3 a , and the magnetically permeable material section is composed of a highly magnetically permeable material 42 a and a magnetically permeable material encapsulating membrane 41 a , in which the highly magnetically permeable material 42 a can be made of an
  • PEBAX and silicone rubber, as well as modified materials of the above materials, and the magnetic field source encapsulation membranes 31 a , 31 b and 31 c as well as the magnetically permeable material encapsulation membranes 41 a and 41 b are all made of the same material as the flexible rods.
  • the present invention provides an article comprising the magnetic nanoparticle, in which the magnetic nanoparticle is further processed to form a stone-removing solution (using physiological saline, buffer as solvent) or a stone-removing powder, preferably a stone-removing solution, which is used as a medical clinical article.
  • a stone-removing solution using physiological saline, buffer as solvent
  • a stone-removing powder preferably a stone-removing solution
  • the basic principle of the high performance system for removing a stone in urinary system which consists of the functional magnetic nanoparticle and the magnetic probe rod as shown, is achieved by the following steps: 1) pulverization of stones in vivo; 2) injection of the functional magnetic nanoparticles, the magnetic nanoparticles having excellent dispersibility (dispersibility and dispersion coefficient are related, the smaller the dispersion coefficient, the better the dispersibility); 3) interaction between the functional magnetic nanoparticles and the stones; 4) surrounding the stones with the functional magnetic nanoparticles (wherein, the surrounding stones is closely related to the dispersibility of the magnetic particles, the better the dispersibility and the better the effect of the surrounding stones); 5) physical or chemical crosslinking of the magnetic nanoparticles on the surface of the stones; 6) removal of the magnetized stones under the guidance of an external magnetic field (wherein, the effect of removing stones by guide is closely related to the effect of surrounding the stones, the better the effect of surrounding the stones, the better the effect of removing the stones).
  • the stones are surrounded and magnetized by the magnetic nanoparticles via physical adsorption, chemical bonding and the like.
  • the physical adsorption mainly refers to an attraction generated by van der Waal's force and hydrophobic interaction within the range of action between hydrophobic magnetic particles—particles and between particles—stones, so that the surface of the stones are adsorbed and surrounded by the magnetic particles;
  • the chemical bonding mainly refers to the interaction between the hydrophilic magnetic nanoparticles—particles and between particles—stones mainly through the formation of chemical bonds (chemical bonds, such as hydrogen bonds, covalent bonds, etc., between carboxyl on the surface of the particles and the stones), so that the surface of the stones is surrounded with the magnetic particles;
  • the chemical bonding includes: the functional magnetic nanoparticles (such as photosensitive, thermosensitive nanoparticles, etc.) firstly act on the stones via physical adsorption, and then further enhance the mutual force between particles—particles and particles—stones via photosensitive crosslinking,
  • the dropping manner of the monomer for the surface-modifier monomer or the weight percentage of the shell formed by the monomer of the surface-modifier with regard to the nanoparticle has significant influences on the dispersibility, as shown in FIGS. 18-21 .
  • the suspension of the synthesized Fe 3 O 4 magnetic particles was poured into a 50 ml centrifuge tube, a powerful magnet was used to attract the magnetic particles, liquid waste was discarded, deionized water was added, the magnetic particles were re-suspended under ultrasonic, so repeatedly to wash away excess ammonia until pH showed neutral.
  • the collected magnetic particles were placed in an oven at 65° C. to be dried and dewatered.
  • the synthesized magnetic particles were weighed, and 1.0 ml suspension of 0.02 mg/ml magnetic particles was formulated for measurement of particle size. A total of 1.5 ml of 0.02M sodium oleate solution was added dropwise to 1.0 ml suspension of 0.2 mg/ml magnetic particles, reacted at 70° C.
  • the black product obtained by centrifugation was redissolved in n-hexane containing 50 ⁇ L of oleic acid and 50 ⁇ L of oleylamine, centrifuged at 600 rpm for 10 minutes to remove insoluble residues.
  • the resulting 4 nm Fe 3 O 4 product was precipitated with ethanol, centrifuged at 600 rpm for 10 minutes to remove solvent and then redispersed into n-hexane.
  • the following different methods were used respectively to synthesize surface-functionalized nanoparticles with different sizes.
  • MnFe 2 O 4 nanoparticles with an average particle size of 9 nm were added to an aqueous solution/3-chloropropionic acid solution with a concentration of 1.0 mol/L initiator, the solution was adjusted to pH of 4 with hydrochloric acid, and stirred overnight.
  • the nanoparticles were collected with a magnet, washed with water for several times to remove excess 3-chloropropionic acid.
  • 0.22 g of dried nanoparticles were added to 8 mL of polystyrene solution under continuous feeding of nitrogen gas, followed by the addition of 4 mL of an xylene solution of 0.3 mmol of CuCl and 1.1 mmol of 4,4′-dinonyl-2,2-dipyridine. The above mixture reacted at 130° C. for 24 h under continuous agitation.
  • the nanoparticles were collected with a magnet and washed repeatedly with toluene to obtain polystyrene-surrounded magnetic iron oxide nanoparticles.
  • Example 1 1 g of Fe 3 O 4 obtained in Example 1 (for example, 10 nm Fe 3 O 4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out under stirring at 80° C. for 3 hours. After the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe 3 O 4 , and vacuum-dried for 12 hours.
  • a silane coupling agent methacryloxypropyltrimethoxysilane, KH570
  • silane coupling agent-activated Fe 3 O 4 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, reacted under under nitrogen protection and stirring at 40° C. for 10 minutes. Then, 4 ml of acrylic acid was slowly dropped into the flask, and reacted under nitrogen protection and stirring al 3) 40° C. for 1 hour. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried under vacuum.
  • the synthesis method of photosensitive monomer with photo-crosslinking characteristics comprised: 4-vinylbenzophenone (4VBP) and styrene monomer were directly polymerized by atom transfer radical polymerization (ATRP) to obtain a photosensitive polystyrene-polyvinylbenzophenone copolymer (PS-PVBP), wherein the specific steps were as follows: in a dry Schlenk tube connected with a reflux condenser, Cu(I)Br (0.695 mg, 4.8 umol), 4VBP (1.0 g, 4.8 mmol), styrene (2 u, 20 umol) and 4-vinylbenzophenone (1 ⁇ L, 4.8 umol) were added, and the mixture was degassed for three times by means of freeze-pump-thaw circulation.
  • 4VBP 4-vinylbenzophenone
  • ATRP atom transfer radical polymerization
  • Methyl bromopropionate (5.35 ⁇ L, 48 umol) was added to the above mixture at ⁇ 78° C. under condition of nitrogen with positive pressure, and the mixture was degassed again for three more times by means of freeze-pump-thaw circulation. Polymerization was carried out by heating the mixture to a temperature of 85° C. under negative pressure, and the reaction was allowed to proceed for 4 hours. The above Schlenk tube was immersed in liquid nitrogen, and 10 ml of dichloromethane was added to dissolve the polymer.
  • PS 75 -PVBP 25 -PAA 100 could be obtained by adding hydrophilic monomer acrylic acid.
  • (Polystyrene 75 -co-polyvinylbenzophenone 25 )-polyacrylic acid 100 was chosen as a polymer to form micelles in aqueous solution.
  • 5 mg of (PS 75 -co-PVBP 52 ) 115 -b-PAA 100 and 10 mg of Fe 3 O 4 obtained in Example 1 were dissolved in 10 ml of dimethylformamide (DMF) solution; and then double distilled water (0.1 ml/min) was gradually added under vigorous stirring.
  • DMF dimethylformamide
  • the resulting solution was added to a dialysis membrane with a molecular weight cut off of 12K-14K and dialyzed against water for 24 hour to remove DMF, and then the micellar solution was transferred to a quartz tube and irradiated with a laser at different time periods (emission wavelength: 315-400 nm) to form a photosensitive monomer-surrounded nanoparticle.
  • Example 1 1 g of Fe 3 O 4 obtained in Example 1 (for example, 10 nm Fe 3 O 4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out with stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe 3 O 4 , and vacuum-dried for 12 hours.
  • a silane coupling agent methacryloxypropyltrimethoxysilane, KH570
  • silane coupling agent-activated Fe 3 O 4 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, reacted under nitrogen protection and stirring at 40° C. for 10 minutes. Then, 4 ml of N-isopropylacrylamide aqueous solution was slowly dropped into the flask, and reacted under nitrogen protection and stirring at 40° C. for 1 hour. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried in vacuo.
  • Example 1 1 g of Fe 3 O 4 obtained in Example 1 (for example, 10 nm Fe 3 O 4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH1570) were mixed with 50 ml of xylene in a reaction flask, and reacted under nitrogen protection and stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe 3 O 4 , and dried in vacuo for 12 hours.
  • a silane coupling agent methacryloxypropyltrimethoxysilane, KH1570
  • silane coupling agent-activated Fe 3 O 4 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, reacted under nitrogen protection and stirring at 40° C. for 10 minutes. Then, 4 ml of dimethylaminoethyl methacrylate aqueous solution was slowly dropped into the flask, and reacted at 40° C. for 1 hour under stirring and nitrogen protection. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried in vacuo.
  • a certain amount of stones were weighed, pulverized with a pestle into a powder (particle size 0.5-2 mm), poured into a transparent glass bottle, and PBS solution was added to obtain a stone liquid.
  • the hydrophilically modified magnetic particles of Example 3 at a concentration of 1 mg/ml was used as a separation liquid and added, and then gently shaken. After standing for 5 minutes, separation was carried out with a magnet. During standing, it was observed that the color of the mixture gradually faded, and after 5 minutes, it was observed that the black magnetic particles were adsorbed on the surface of the stone. Under the guidance of the magnetic field, the stones with magnetic particles adsorbed on their surface moved toward the magnet.
  • one 6-week-old nude rat and 3 mice were intraperitoneally injected and tail vein injected, respectively.
  • the hydrophilically modified magnetic nanoparticles of Example 3 at a concentration of 0.5 mg/ml and in an amount of 200 ⁇ L were used for the injection for consecutive two days.
  • the living conditions of the mice were observed periodically (such as one week, two weeks, etc.).
  • the results showed that after intravenous injection of 200 ⁇ L of magnetic nanoparticle solution, no obvious toxicity was found in the nude rat and the mice within 1 week; and after intraperitoneal injection of particle solution at the same concentration 3 times, it was found that the rat and the mice had good survival status within 3 months.
  • an ureteroscope was used for holmium laser lithotripsy.
  • 200 ml of the hydrophilic magnetic nanoparticle solution of Example 3 according to the present invention was injected into the kidney through the working channel of the ureteroscope, so that the hydrophilic magnetic nanoparticle solution was thoroughly mixed with the stone debris. After about 3 minutes, the nanoparticles in the solution completely adhered to the surface of the stone debris, and magnetized the stone debris.
  • the above-mentioned magnetic probe rod system for removal of stones in urinary system in which a NdFeB permanent magnet was used as the magnetic field source 3 , was inserted into the kidney through the working channel of the ureteroscope. Under the action of the magnetic field at the distal end of the magnetic probe rod system, the magnetized stone debris moved closer to the distal end of the magnetic probe rod and attracted to the magnetic probe rod. Finally, the magnetic probe rod system filled with stones debris at its distal end together with the ureteroscope were drawn from the body through the soft sheath of the ureteroscope.
  • the magnetic probe rod could be inserted again into the endoscope to carry out stone removal operation, until all of the stone debris inside the kidney were removed from the body.
  • the stone had a diameter of about 20 mm and was located in the lower kidney calyx.
  • Example 1 1 g of Fe 3 O 4 obtained in Example 1 (for example, 10 nm Fe 3 O 4 obtained by co-precipitation method), 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out under stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe 3 O 4 , and vacuum-dried for 12 hours.
  • a silane coupling agent methacryloxypropyltrimethoxysilane, KH570
  • silane coupling agent-activated Fe 3 O 4 40 mg of potassium persulfate and 30 ml of deionized water were added in the flask, stirred and reacted under protection at 40° C. for 10 minutes.
  • the experiments were carried out to systematically compare the dropping group (manual and gradual dropping of acrylic acid surface-modifier monomer) and the continuous addition group (electronic and continuous dropping of acrylic surface-modifier monomer).
  • the dropping group 4 ml of acrylic acid for manual and gradual dropping was gradually dropped (every 3 seconds) by hand using an injection syringe into the flask, and the reaction was carried out under nitrogen protection and stirring at 40° C. for 1 hour.
  • the monodispersity coefficient of the magnetic nanoparticles was measured, and the specific experimental results were shown in FIG. 18 . It can be seen from FIG. 18 that, in comparison with the monodispersity coefficient (0.478 ⁇ 0.075) of the magnetic nanoparticles of the dropping group, the monodispersity coefficient (0.0043 ⁇ 0.0016) of the magnetic nanoparticles of the continuous addition group was far lower, that is, the magnetic nanoparticles obtained in the continuous addition group have better dispersibility.
  • Example 1 1 g of Fe 3 O 4 obtained in Example 1 (for example, 10 nm Fe 3 O 4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out under stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe 3 O 4 , and vacuum-dried for 12 hours.
  • a silane coupling agent methacryloxypropyltrimethoxysilane, KH570
  • silane coupling agent-activated Fe 3 O 4 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, stirred and reacted at 40° C. for 10 minutes under protection of nitrogen atmosphere.
  • the nanoparticle dispersibilities of the nanoparticles of the following 6 groups were systematically compared: Group 1 (the weight percentage of the shell is 0.5%, with regard to the weight of the particles), Group 2 (the weight percentage of the shell is 1%, with regard to the weight of the particles), Group 3 (the weight percentage of the shell is 2%, with regard to the weight of the particles), Group 4 (the weight percentage of the shell is 15%, with regard to the weight of the particles), Group 5 (the weight percentage of the shell is 40%, with regard to the weight of the particles) and Group 6 (the weight percentage of the shell is 45%, with regard to the weight of the particles).
  • the monodispersity coefficient of the magnetic nanoparticles was measured by the German ALV-CGS3 dynamic and static laser light scattering instrument, and the specific experimental results were as follows: the monodispersity coefficient of the nanoparticles of Group 1 was 0.5 ⁇ 0.04; the monodispersity coefficient of the nanoparticles of Group 2 was 0.026 ⁇ 0.0026; the monodispersity coefficient of the nanoparticles of Group 3 was 0.036 ⁇ 0.003; the monodispersity coefficient of the nanoparticles of Group 4 was 0.022 ⁇ 0.002; the monodispersity coefficient of the nanoparticles of Group 5 was 0.031 ⁇ 0.0028; the monodispersity coefficient of the nanoparticles of Group 6 was 0.58 ⁇ 0.05.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Robotics (AREA)
  • Soft Magnetic Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Hard Magnetic Materials (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a nanoparticle, a preparation method thereof, a stone removing device and its application. The nanoparticle includes a nanoparticle core made of a magnetic material, and a nanoparticle shell formed by attaching a surface modifier monomer to the nanoparticle core with an initiator and/or a crosslinking agent. The prepared nanoparticle can surround stones in ureter, and then small stone remaining in body can be removed quickly without damage from the body under the action of an externally applied magnetic field, that is, the stone can be drawn and moved without injuring ureteral wall, and meanwhile the nanoparticles are placed conveniently without shift.

Description

    TECHNICAL FIELD
  • The present invention relates to nanoparticles and methods of making the same. Further, the present invention also relates to a stone removing device containing nanoparticles and its application.
  • BACKGROUND ART
  • Urinary calculi/stone (urolithiasis) have an incidence as high as 5%-10%, and can be found in any part of kidney, bladder, ureter and urethra, in which stones in kidney and ureter are common. It is found in clinical observation that calcium-containing stones are the most common types of urinary stones, that is, about 70% to 80% of all urinary stones. At present, there are only a few cases of calcium-containing stones which pathological causes have been clearly revealed, while the causes for most of calcium-containing stones are not yet clear. According to chemical composition, stones can be divided into four categories: calcium-containing stones, infection induced stones, uric acid stones and cystine stones. Calcium-containing stones can be divided into following types: simple calcium oxalate, calcium oxalate with calcium phosphate, calcium oxalate with a small amount of uric acid; the main components of infection induced stones are ammonium magnesium phosphate and hydroxyapatite; uric acid stones can be divided into following types: uric acid, uric acid amine, or those containing a small amount of calcium oxalate in addition to the above ingredients; cystine stones can be divided into following types: simple cystine, or cystine with a small amount of calcium oxalate.
  • Soft/hard ureteroscopic lithotripsy is performed through natural channel of the human body, has the advantages of small trauma and definite lithothriptic effect, and is currently the main treatment means for most of ureteral stones and kidney stones. However, the current soft/hard ureteroscopic lithotripsy also has some deficiencies: 1) upper ureteral stones and fragments of stones in ureter may be easily brought back to kidney by the infused water or the recoil force of lithotripsy tools; 2) there is lack of a fast, safe and effective method to take out residual debris of stones in ureteral lumen and kidney calices. It is an an important mean to prevent ureteral stones from being recoiled back to kidney that a tool is used to block the ureter above the ureteral stones. At present, there are also some ureteral occluders in clinical practice, and such kind of stones blocking tools are also commonly used to remove stones. However, these ureteral occluders still have some shortcomings in actual use. Stone baskets (such as various stone baskets described in Patent Publication No. JP2009536081 A, DE19904569A1, WO2004056275A1, WO2011123274A1 are designed with a net bag) are the most commonly used stone interception and removal tools, which cross over stone and then are opened to form a net so as to prevent the upward drift of stone debris, and at the same time, the stone baskets are also used as stone removal tools to net and take out small stone debris. However, the amount of stone removed by the stone basket every time is limited, so that multiple feeds of ureteroscope are needed, while repeated injection of water and feeds of ureteroscope would increase the risk of residual debris drift; in addition, the stone basket can not completely seal the ureteral lumen, and there are still a chance that stones escape from the net; moreover, the edges of stones in stone basket may be easily squeezed out from basket holes, and thus may easily scratch the ureter wall when the stones are dragged and removed, thereby causing complications in severe cases.
  • In addition, CN105283140A describes a kit of a cross-linked gel for encapsulating urethral stones and/or debris of urethral stones. However, when a gel-containing magnetic reagent (mock) is added to an aqueous solution containing stones, the cationic polymer is dispersed substantially in the form of dissolving in a solvent rather than aggregates to the periphery of stones due to the principle of similar compatibility, which is not sufficient to magnetize stones and remove stones.
  • In summary, there is an urgent need for a material and method for removal of stones in urinary system that can collect stones, facilitate the stone taking, do not damage the ureteral wall when the stones are dragged, can be conveniently placed and are not easy to cause shift of stone.
  • Contents of the Invention
  • The present invention is aimed to solve the problem of residual stone debris and difficult removal thereof in the conventional soft/hard ureteroscopic lithotripsy. Therefore, a first object of the present invention is to provide a nanoparticle that can be used safely and efficiently to remove a stone located at a position such as kidney, ureter and so on in an urinary system, and the nanoparticle has excellent dispersibility. A second object of the present invention is to provide a method for preparing the nanoparticle with different morphological structures. A third object of the present invention is to provide a use of the nanoparticle in coordination with a selfmade magnetic probe rod system in an operation of urinary calculi; a fourth object of the present invention is to provide a use of the nanoparticle in manufacture of an article for removing a stone in urinary system.
  • According to the first aspect of the present invention, there is provided a nanoparticle comprising a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by attaching a surface modifier monomer to the nanoparticle core with an initiator and/or a crosslinking agent.
  • According to some embodiments of the present invention, the nanoparticle comprises: a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent; wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the weight percentage of the shell is 0.5-45% (excluding end points), preferably 1-40%, more preferably 2-40%, further more preferably 1-15% or 2-15%, most preferably 1%, 2%, 15% or 40%, with regard to the weight of the nanoparticles.
  • According to some embodiments of the present invention, the nanoparticle comprises: a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent, wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the method for preparing the magnetic nanoparticle core is a co-precipitation method, wherein a solution of the magnetic material and a catalyst are added in the manner of electronic pump-assisted continuous dropping.
  • In another embodiment, the nanoparticle comprises: a nanoparticle core made of a magnetic material; and a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent; wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the method for preparing the magnetic nanoparticle core is a co-precipitation method, wherein the surface modifier monomer is added in the manner of electronic pump-assisted continuous dropping.
  • According to some embodiments of the present invention, the nanoparticle surrounds a stone through physical adsorption, chemical bonding, and photosensitive, thermosensitive, and pH-sensitive crosslinking; specifically, the mutual forces for binding and surrounding between the nanoparticles and the stone include: van der Waal's force that form an interacting surrounding, hydrophobic interaction, adsorption and surface deposition; covalent bonds formed between carboxyl-stone, including hydrogen bonds, ester bonds, amide bonds, and other covalent bonds; interacting physical entanglement and chemical crosslinking between chains.
  • According to some embodiments of the present invention, the nanoparticle core has a diameter of 2-50 nm, and a weight percentage of 30-95% with regard to the whole weight of the nanoparticle, and the magnetic material constituting the core includes a compound of Fe3+, Fe2+, Mn2+ or Ni2+, or a metal element selected from iron, nickel, copper, cobalt, platinum, gold, europium, gadolinium, dysprosium, terbium, or a composite or oxide of the aforementioned metals, or any one of the above items or a combination of two or more of the above items, preferably one of or a combination of any two of Fe3+, Fe2+, Mn2+ or Ni2+, more preferably Fe3+ and Fe2+ in a ratio of 15% to 85%, preferably 1:2.5 to 1.5:1. It should be noted that the method for preparing the nanoparticle used in the present invention can well control the size and dimension of the magnetic nanoparticle core; especially, in comparison with the nanoparticles prepared by other methods, among the parameters of the nanoparticle obtained in the present invention that relates to the biomedical application, the dispersibility of the nanoparticle is very good and less than 1.1.
  • According to certain embodiments of the present invention, the surface modifier includes a hydrophilic surface modifier with function response, a hydrophobic surface modifier with function response, a photosensitive surface modifier with function response, a thermosensitive surface modifier with function response or a pH sensitive surface modifier with function response, wherein the hydrophilic surface modifier includes acrylic acid, methacrylic acid, isobutyl acrylamide or poly N-substituted isopropylacrylamide; the hydrophobic surface modifier includes olefins, preferably polystyrene, polyethylene or oleic acid; the photosensitive surface modifier is selected from the group consisting of azos and quinolines and benzophenones (PVBP), preferably vinyl benzophenone; the thermosensitive surface modifier is selected from the group consisting of amphiphilic polymers with an amide bond, preferably polyacrylamide or poly N-substituted isopropylacrylamide; the pH-sensitive surface modifier is selected from the group consisting of polymers with a carboxyl group and a quaternary ammonium salt, preferably polyacrylic acid, dimethylaminoethyl ester and dimethylaminopropyl methacrylate.
  • According to certain embodiments of the present invention, the crosslinking agent includes 3-(methacryloyloxy)propyltriethoxysilane, divinylbenzene, diisocyanate or N,N-methylenebisacrylamide, and the initiator includes 3-chloropropionic acid, CuCl, 4,4′-dinonyl-2,2-bipyridine or potassium persulfate.
  • The second aspect of the invention provides a method of preparing the nanoparticle, including the steps of: a) preparing the nanoparticle core using the magnetic material; and b) forming the nanoparticle shell by in-situ linking the surface modifier monomer to the nanoparticle core by the initiator and/or crosslinking agent. As used herein, “in-situ” means that the surface modifier is directly attached to the surface of the nanoparticle core. The resulting modified nanoparticle has a size between 50 nm and 5000 nm, which varies according to different conditions.
  • According to some embodiments of the present invention, the nanoparticle core is composed of Fe3O4, MnFe2O4, γ-Fe2O3, or other nanoscale-sized ferrite particles, and these ferrite particles are prepared by the following steps:
  • dissolving a proportion of the metal salt-containing material in water;
  • feeding nitrogen to expel oxygen in the solution;
  • adding a catalyst at a room temperature of 20-30° C. to adjust the pH to 8-12, preferably 10;
  • keeping agitation and reaction for 20-40 minutes; and
  • reacting under condition of 50-100° C., preferably 70° C. water bath, for 20-40 minutes, then separating with a magnet and drying to obtain the magnetic nanoparticle core.
  • In a particular embodiment of the present invention, the oxygen-containing metal salt is FeCl3.6H2O and FeCl?2.4H2O, which are dissolved in water in a molar ratio of 15% to 85%, preferably 1:2.5 to 1.5:1, wherein the catalyst is aqueous ammonia. Fe3O4 nanoparticles can be obtained by following the above steps.
  • According to some embodiments of the present invention, the step b) includes dispersing the prepared nanoparticles in an aqueous solution, adding with an xylene solution of 3-chloropropionic acid, polystyrene, CuCl and 4,4′-dinonyl-2,2-bipyridine, wherein the molar ratio between the solution of iron particles and the reaction solution is 1:1; reacting the mixture for 15-30 hours, preferably 24 hours, at 130° C. under continuous agitation; and collecting the nanoparticles with a magnet, washing repeatedly with toluene to obtain hydrophobic polystyrene-surrounded magnetic iron oxide nanoparticles.
  • According to some embodiments of the present invention, the step b) includes dissolving and dispersing the resulting nanoparticle core into xylene, adding with a silane coupling agent, wherein the silane coupling agent, wherein the nanoparticles, xylene and silane coupling agent are added in a ratio of 95:5; reacting under the protection of nitrogen atmosphere at 20-100° C., preferably at 80° C., for 2-5 hours, preferably for 3 hours; washing with an alcoholic solvent (preferably absolute ethanol) and drying for 12 hours, dispersing in an aqueous solution under ultrasonic condition, adding with potassium persulfate; reacting under nitrogen protection, at 40-80° C. for 10 minutes, adding with acrylic acid to continue reaction at 40-80° C. for 1 hour, wherein the reaction temperature is preferably 70° C.; and separating with a magnet, washing and drying to obtain the polyacrylic acid-modified hydrophilic nanoparticles.
  • According to some embodiments of the present invention, the above step b includes: dissolving and dispersing Fe3O4 nanoparticles into xylene, and adding with a silane coupling agent, wherein the silane coupling agent (the ratio of the Fe3O4 nanoparticles and the silane coupling agent as added is 95:5); reacting under protection of nitrogen atmosphere at 80° C. for 2-5 hours, preferably for 3 hours; washing with an alcoholic solvent (preferably absolute ethanol) and drying for 12 hours, dispersing in an aqueous solution under ultrasonic condition, adding with potassium persulfate; reacting under nitrogen protection at 40-80° C. for 10 minutes, adding with a photosensitive monomer such as vinyl benzophenone, a thermosensitive monomer such as N-isopropylacrylamide, or a pH-sensitive monomer such as dimethylaminopropyl methacrylate, etc. (or a blended monomer of acrylic acid and styrene), reacting continuously for 1 hour at 40-80° C., preferably at 70° C.; and separating with a magnet, washing and drying to obtain the photosensitive, thermosensitiveor pH sensitive functional monomer-modified magnetic nanoparticles, respectively.
  • In certain embodiments of the present invention, the photosensitive monomer modification based on the hydrophilic surface modification includes: dissolving and dispersing the polyacrylic acid-modified magnetic nanoparticles in an alcoholic solvent, dispersing for 5-30 minutes under ultrasonic condition, then adding an initiator and a photosensitive monomer polyvinylbenzophenone, refluxing and reacting at agitation and 130° C. for 24 hours under condition that oxygen is kept out to prepare the photosensitive monomer-modified magnetic nanoparticles.
  • In the above embodiment, when aqueous ammonia is used as catalyst to prepare the nanoparticles, the method for dropping aqueous ammoniais performed in a continuous and dropwise manner with assistance of an electronic pump at a speed of 20-100 drops/minute, preferably 40-60 drops/minute; and when the magnetic material is an element material, the liquid monomer is added in a dropwise and continuous manner with assistance of an electronic pump, and the reaction is carried out under agitation with a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
  • It should be noted here that the particle size, distribution and morphology (such as shape of sphere, rod, diamond, etc.) of the obtained magnetic nanoparticle core can be relatively easily controlled under the synthetic methods and preparation conditions as we designed above. Furthermore, the surface-modified magnetic nanoparticles prepared by the above method have particle size and distribution superior to those of magnetic nanoparticles obtained by conventional preparation methods. As shown in the following table, the dispersibility index (PD.I.) of the obtained nanoparticles is basically close to 1.0, which clearly shows that the particle size distribution of the obtained particles is narrow. This is very important because, for in vivo biomedical applications, the size and dispersion of nanoparticles determine the breadth of their medical applications. The PD.I described herein for describing the dispersibility of nanoparticles is defined as follows:

  • PD.I.==<Rh 2 >/<Rh> 2
  • wherein, Rh represents hydrodynamic radius of particle.
  • The nanoparticle core and the surface-modified magnetic nanoparticle have distribution PD.I. as shown in the following table:
  • Magnetic nanoparticle core After surface modification
    Diameter/nm 40-50 80-100
    PD.I./a.u. 0.005 0.0055
  • In addition, as shown in FIG. 2, the structure of the nanoparticles obtained in the present invention is clear.
  • According to the third aspect of the present invention, there is provided a device for removal of stone, which can be used in the urinary system and consists of a magnetic nanoparticle in combination with a stone-removal magnetic probe rod system. The device for removal of stone comprises the above-mentioned nanoparticles of the present invention and an auxiliary stone-removal magnetic probe rod system. The device for removal of stone can be used for removing a stone in urinary system such as kidney stone, ureteral stone and bladder stone, etc., as well as removing a stone in human biliary system and a stone-like particle in other organs.
  • Specifically, the stone-removal magnetic probe rod system comprises a handle, a flexible rod, a magnetic field source, a magnetically permeable material section, etc., in which the handle may be provided with an AC or DC power supply, a power switch, a DC battery compartment and an AC plug; the flexible rod is made of a polymer material including, for example, PU, TPU, PE, PVC, NYLON, PEBAX and silicone rubber and the modified materials of the above materials, the magnetic field source made of a permanent magnet or electromagnet can be embedded in the flexible rod, and optionally a high performance magnetically permeable material is connected to the magnetic field source to form the flexible probe rod with different configurations, for example, the permanent magnet is placed in the middle or back end of the flexible rod, and the magnetically permeable material is placed in the distal end of the flexible rod, so that such configuration is more conducive to the treatment of renal stones under ureteroscope to avoid the situation that the distal end of the flexible rod becomes rigid due to the rigid structure of the permanent magnet or the electromagnet, so that such magnetic probe rod can be successfully inserted into the working channel of ureteroscope, and inserted into upper, middle and lower kidney calices to carry out stone removal operation when driven by the ureteroscope.
  • In the forth aspect of the invention, there is provided an article comprising the nanoparticle of the present invention, in which the nanoparticle is prepared in the form of a solution or powder.
  • The invention provides a novel preparation process for synthesizing hydrophilic, hydrophobic, thermosensitive and pH-sensitive as well as photosensitive magnetic nanoparticles, which has the advantages of simple preparation process, good repeatability and convenient application. By the hydrophobic interaction between the prepared hydrophobic nanoparticles and stones, the chemical bond interaction between hydrophilic nanoparticles and stones, and the polymerization of the photosensitive nanoparticles under illumination, the stones are surrounded; and the thermosensitive and pH-sensitive nanoparticles can surround stones through physically surrounding action in ureter; thereby, small stone remaining in body can be removed quickly without damage from the body under the action of an externally applied magnetic field, that is, the stone can be drawn and moved without injuring ureteral wall, and the nanoparticles are placed conveniently without shift.
  • The present invention is further described with reference to the accompanying drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows the transmission electron microscope (TEM) images and the particle size distribution diagrams under dynamic light scattering for the cores with different morphologies obtained in Example 1 of the present invention.
  • FIG. 2 shows the particle size distribution diagram under dynamic light scattering for the monomer-modified nanoparticles obtained in Example 4 of the present invention; and TEM images of the monomer-modified nanoparticles obtained in Example 3 of the present invention.
  • FIG. 3 shows the hysteresis curves of the monomer-modified nanoparticle cores with different Fe3+/Fe2+ ratios in the synthesis of the nanoparticles obtained in Example 3 of the present invention.
  • FIG. 4 shows the graphs of stone separation for the photosensitive monomer-modified nanoparticle cores obtained in Example 4 of the present invention, and the graphs of separation performance for the nanoparticle cores synthesized with different Fe3+/Fe2+ ratios and modified with functional monomer.
  • FIG. 5 shows a graph of biocompatibility to 293t cells for the functional magnetic nanoparticles obtained in Example 4 of the present invention.
  • FIG. 6 shows a graph of stone separation with in vitro assistance for the nanoparticles obtained in Example 6 of the present invention.
  • FIG. 7 shows a graph of safety evaluation in body of animals for the nanoparticles of the present invention.
  • FIG. 8 shows an overall schematic diagram of the magnetic probe rod system for assisting stone removal in the present invention.
  • FIG. 9 shows a schematic view of the handle portion of the magnetic probe rod system for assisting stone removal in the present invention.
  • FIG. 10 shows a schematic view of the magnetic probe rod system with an AC power supply for assisting stone removal according to the present invention.
  • FIG. 11 shows a schematic view of the internal structure of the magnetic probe rod system using an electromagnet as magnetic field source according to the present invention.
  • FIG. 12 shows a schematic view of the magnetic probe rod system of the present invention which uses an electromagnet as magnetic field source and a magnetically permeable material section at distal end.
  • FIG. 13 shows a schematic view of the magnetic probe rod system of the present invention which uses a permanent magnet as magnetic field source and a magnetically permeable material section at distal end.
  • FIG. 14 shows a schematic view of the magnetic probe rod system of the present invention which uses a permanent magnet as magnetic field source and has not a magnetically permeable material section at distal end.
  • FIG. 15S shows a diagram of the principle of interaction between magnetic particles and stones.
  • FIG. 16 shows a diagram of agitation of the reaction system in steps 2-4) of the method for preparing the nanoparticles of the present invention, which uses a magnetic stirrer at a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
  • FIG. 17 shows a diagram of the steps 1-4) of the method for preparing the nanoparticles according to the present invention, in which aqueous ammonia and liquid monomer are added dropwise continuously and uniformly by an electronic pump at a rate of 20-100 drops/minute, preferably 40-60 drops/minute.
  • FIG. 18 shows the effect of addition mode of the surface modifier monomer on the particle dispersibility.
  • FIG. 19 and FIG. 20 show TEM images of the particles after continuous addition and dropping.
  • FIG. 21 shows the effect of the weight percentage of the nanoparticle shell with regard to the nanoparticle on the dispersibility of the nanoparticle.
  • SPECIFIC MODELS FOR CARRYING OUT THE INVENTION
  • The present invention is further illustrated below with reference to the accompanying drawings and specific examples. It should be understood that the following examples are only used to illustrate the present invention, rather than to limit the scope of the present invention.
  • According to a first aspect of the present invention, there is provided a magnetic nanoparticle with good dispersibility, capable of safely and efficiently removing stones in urinary system. The present invention provides a functional magnetic nanoparticle, comprising: hydrophilic, hydrophobic, photosensitive, thermosensitive, pH-sensitive magnetic nanoparticles, which morphology can be spherical, rod-shaped and the like, which structure can be of core-shell structure consisting of a magnetic core and a monomer modifier such as hydrophilic, hydrophobic, temperature sensitive, pH-sensitive or photosensitive surface modifiers as well as a small amount of initiator; in which the hydrophilic surface modifier forms a hydrophilic shell by polymerization to surround the magnetic nanoparticle core, including the hydrophilic materials with positive charges, negative charges and electricity neutrality; the hydrophobic surface modification is carried out by a poor water-soluble polymer or inorganic material; the other functional materials such as photosensitive, thermosensitive and pH-sensitive monomer modifiers may be polymerized by a crosslinking agent and embedded in a hydrophobic shell, or these monomer modifiers may be in-situ and directly attached to the surface of the core by an initiator and/or crosslinking agent.
  • Among the various kinds of responsive magnetic nanoparticles such as hydrophilic, hydrophobic, thermosensitive, pH-sensitive and photosensitive magnetic nanoparticles, the materials for synthesizing magnetic nanoparticle cores comprise Fe3+, Fe2+ and Mn2+, Ni2+ compounds, as well as metal elements such as iron (Fe), nickel (Ni), copper (Cu), cobalt (Co), platinum (Pt), gold (Au), europium (Eu), gadolinium (Gd), dysprosium (Dy), terbium (Tb), or composites and oxides of the metals, such as Fe3O4 or MnFe2O4, preferably iron, manganese or their compounds; also preferably, any one of them or any combination of two or more of them may be used; and the core has a size of 2-50 nm.
  • The preparation method of the magnetic nanoparticle core includes co-precipitation methods, emulsion methods, redox reaction or high-temperature high-pressure methods. The weight percentage of the magnetic nanoparticle core is 30% to 95% with regard to the total weight of the functional magnetic nanoparticle, taking the synthesis of Fe3O4 as example, the ratio of Fe3+ to Fe2+ is 15% to 85%, preferably 1:2.5 to 1.5:1 for Fe3+ and Fe2+.
  • The surface of the magnetic nanoparticle can be subjected to functional modification, such as hydrophilic modification, hydrophobic modification, and modification with photosensitive, thermosensitive and pH-sensitive materials.
  • According to a first embodiment of the present invention, there is provided a hydrophilically modified functional particle, wherein the core size is 2-50 nm, the magnetic nano-core has a weight of 30-95% with regard to the total nanoparticle; the hydrophilic surface modifier is a polycationic or an anionic polymer, such as acrylic acid, methacrylic acid and isobutyl acrylamide, etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle. The magnetic core particle is attached on its surface with an initiator such as 3-chloropropionic acid or the like, then a polymer based on acrylic acid, methacrylic acid and isobutyl acrylamide or the like is modified on the particle surface with a crosslinking agent by a chemical reaction, such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the shape of the particle may be spherical, rod-shaped and layered, preferably spherical particles. The crosslinking to agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • According to a second embodiment of the present invention, there is provided a hydrophobically modified functional particle, wherein the core has a size of 2-50 nm, the magnetic nano-core is 30-95% by weight with regard to the whole nanoparticle; the hydrophobic surface modifier is an water insoluble monomer, such as olefins, for example, polystyrene and the like, which weight percentage is 2-8% by weight with regard to the whole hydrophobic magnetic nanoparticle. The magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a hydrophobic polymer based on styrenes is modified on the particle surface by a crosslinking agent via a chemical reaction such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the morphology of the particle may be spherical, rod-shaped and layered, preferably spherical particle. The crosslinking agent is 3-(methacryloyloxy) propyl triethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • According to a third embodiment of the present invention, there is provided a photosensitive surface-modified functional particle, wherein the core has a size of 2-50 nm, and the magnetic core is 30-95% by weight with regard to the whole nanoparticle; the photosensitive modifier is selected from the group consisting of azos and quinolines as well as benzophenones (PVBP), etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle. The magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a photosensitive polymer based on benzophenone (PVBP) and the like is modified to the surface of the particle by a crosslinking agent via a chemical reaction such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the morphology of the particle may be spherical, rod-shaped and layered, preferably spherical particle. The crosslinking agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • According to a fourth embodiment of the present invention, there is provided a thermosensitive surface-modified functional particle, wherein the size of the core is 2-50 nm, and the magnetic nano-core is 30-95% by weight with regard to the whole nanoparticle; the thermosensitive surface modifier is selected from the group consisting of amphiphilic polymers carrying amide bonds, such as polyacrylamide, poly N-substituted isopropylacrylamide, etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle. The magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a thermosensitive polymer such as poly N-substituted isopropylacrylamide is modified to the surface of the particle by a crosslinking agent via a chemical reaction such as radical, ring-opening assembly and atom transfer radical polymerization (ATRP); the shape of the particle may be spherical, rod-shaped and layered, preferably spherical particle. The crosslinking agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • According to a fifth embodiment of the present invention, there is provided a pH-sensitive surface-modified functional particle, wherein the core has a diameter of 2 to 50 nm, the magnetic nano-core is 30 to 95% by weight with regard to the whole nanoparticle; the pH-sensitive surface modifier is selected from the group consisting of polymers carrying carboxyl groups and quaternary ammonium salt groups, such as polyacrylic acid, dimethylaminoethyl ester and dimethylaminopropyl methacrylate, etc., which weight percentage is 2-8% with regard to the whole hydrophobic magnetic nanoparticle. The magnetic core particle is attached to its surface with an initiator such as 3-chloropropionic acid, and then a pH-sensitive polymer based on dimethylaminoethyl methacrylate and dimethylaminopropyl methacrylate or the like is modified to the surface of the particle by a crosslinking agent via a chemical reaction such as radical, ring-opening polymerization and atom transfer radical polymerization (ATRP); the shape of the particle may be spherical, rod-shaped and layered, preferably spherical particle. The crosslinking agent is 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA) and the like.
  • In the above embodiments of the present invention, an initiator and/or a crosslinking agent are further included. The initiator includes thermal initiators, for example, potassium persulfate, ammonium persulfate and azo type initiators; the crosslinking agent includes 3-(methacryloyloxy) propyltriethoxysilane (MPS), divinylbenzene and diisocyanate or N,N-methylenebisacrylamide (MBA), molecular weight is 100,000, and oleic acid, etc.
  • According to a second aspect of the present invention, there is provided a preparation method for a nanoparticle. The preparation method generally includes two main steps: synthesis of a magnetic nanoparticle core, and various surface modifications based on the magnetic nanoparticle core (hydrophilic, hydrophobic and thermosensitive, photosensitive and pH-sensitive modification). Taking the preparation of magnetic Fe3O4 nanoparticles as an example, the two steps of the preparation method are respectively described in detail.
  • 1) Preparation of Magnetic Fe3O4 Nanoparticle Core
  • FeCl3.6H2O and FeCl2.4H2O in a certain molar ratio (the molar ratio of FeCl3.6H2O and FeCl2.4H2O is 15% to 85%, preferably 1:2.5 to 1.5:1) are dissolved in 100 mL of water, fed with nitrogen gas to expel oxygen in the solution, added with aqueous ammonia at a room temperature of 20-30° C. to adjust the pH value of 8-12, preferably 10, and kept agitation and reaction for 20-40 minutes; then under a 50-100° C., preferably 70° C. water bath, the reaction is carried out for 20-40 minutes, and then Fe3O4 nanoparticles are obtained by separation with a magnet and drying. There are different kinds of preparation methods such as co-precipitation method, thermal decomposition method, hydrothermal synthesis method, microemulsion method (reverse micelle method) and the like.
  • 2) Surface Modification of the Synthesized Fe3O4 Nanoparticle Core
  • 2.1) Hydrophobic Modification of the Surface of the Synthesized Fe3O4 Nanoparticle Core
  • The Fe3O4 nanoparticle core prepared in the step 1) is dispersed into an aqueous solution, added with an initiator 3-chloropropionic acid and pre-treated for 12 hours, then added with an xylene solution of a hydrophobic surface-modifying monomer polystyrene and an active initiator CuCl and 4,4′-dinonyl-2,2-dipyridine (the molar ratio of the iron particle solution and the reaction solution is 1:1), and the mixture solution is reacted under continuous agitation at 130° C. for 15-30 hours, preferably 24 hours; the resulting nanoparticles are collected with a magnet and washed repeatedly with toluene to obtain the hydrophobic polystyrene-surrounded magnetic iron oxide nanoparticles.
  • Here, 3-chloropropionic acid is used as an initiator, and CuCl and 4,4′-dinonyl-2,2-bipyridine are used as another initiator. In addition, according to one embodiment of the present invention, the reaction time is preferably 18 to 30 hours, preferably 24 hours. In addition, according to one embodiment of the present invention, the solvent is toluene or xylene in an amount of ½ to 1 of the monomer volume, the mass ratio of the surface-modified polystyrene magnetic nanoparticles, the initiator and the monomer is 95:0.5:4.5.
  • 2.2) Hydrophilic Modification of the Surface of the Synthesized Fe3O4 Nanoparticle Core
  • The Fe3O4 nanoparticle core obtained in the above step 1) is dissolved and dispersed into xylene, added with a silane coupling agent (the addition ratio of Fe3O4, nanoparticles and the silane coupling agent is 95:5), and reacted at 80° C. under nitrogen protection for 2-5 hours, preferably 3 hours; then washed with an alcoholic solvent (preferably absolute ethanol) and dried for 12 h, dispersed in an aqueous solution under ultrasonic condition, added with potassium persulfate; reacted under nitrogen protection at 40-80° C. for 10 minutes, then added with acrylic acid and reacted continuously at 40-80° C. for 1 hour, preferably reacted at a reaction temperature of 70° C.; separated by a magnet, washed and dried to obtain polyacrylic acid-modified, hydrophilic surface-modified magnetic nanoparticles.
  • Here, the silane coupling agent is 3-(methacryloyloxy)propyltriethoxysilane (MPS) in an amount of 8 to 16 times the mass of acrylic acid; the solvent is benzene or 2-toluene; potassium persulfate is used as initiator; the reaction time is preferably 20 minutes to 80 minutes. According to one embodiment of the present invention, the mass ratio of the surface-modified magnetic Fe3O4 nanoparticles, the potassium persulfate and the acrylic acid monomer is 25-100:1:100.
  • In addition, the alcoholic solvent here is methanol, ethanol or butanol, preferably ethanol, the reaction temperature is preferably 100° C. to 150° C., the reaction time is preferably 18 hours to 24 hours, and the mass ratio of the photosensitive monomer-modified magnetic nanoparticles, the potassium sulfate and the vinylbenzophenone monomer is 25-100:1:100.
  • 2.3) Functional Modification of the Surface of the Synthesized Fe3O4 Nanoparticle Core
  • The Fe3O4 nanoparticle core as prepared in the above step 1) is dissolved and dispersed into xylene, added with a silane coupling agent (the addition ratio of the Fe3O4 nanoparticles and the silane coupling agent is 95:5), reacted under nitrogen protection at 80° C. for 2-5 hours, preferably 3 hours, then washed with an alcoholic solvent (preferably absolute ethanol) and dried for 12 hours, dispersed into an aqueous solution under ultrasonic condition, added with potassium persulfate; reacted under nitrogen protection at 40-80° C. for 10 minutes, then added with a photosensitive monomer vinyl benzophenone, or a thermosensitive monomer N-substituted isopropylacrylamide, or a pH-sensitive monomer dimethylaminoethyl methacrylate, reacted at 40-80° C. for 1 hour, preferably reacted at a reaction temperature of 70° C.; separated by a magnet, washed and dried to obtain magnetic nanoparticles with photosensitive, thermosensitive or pH-sensitive surface modification, respectively.
  • In addition, the functionally modified nanoparticles here may also be obtained by a cross-reaction with steps 2.1 and 2.2) and step 3) after pre-modification of the surface of the nanoparticle in the steps 2.1 and 2.2). That is, after the modification of 3-chloropropionic acid in step 2.1 (or the modification of silane coupling agent in step 2.2), the hydrophobic monomer styrene (or hydrophilic monomer acrylic acid) and the functional monomer such as vinyl benzophenone, N-substituted isopropylacrylamide or dimethylaminoethyl methacrylate and the like are added at the same time, and reacted at 40-80° C. for 1 hour, preferably reacted at a reaction temperature of 70° C.; separated by a magnet, washed and dried to obtain magnetic nanoparticles with photosensitive, thermosensitive or pH-sensitive surface modification. The co-reaction would result in co-modified functional nanoparticles corresponding to polystyrene (or polyacrylic acid) and the functional monomer.
  • Here, the silane coupling agent is 3-(methacryloyloxy)propyltriethoxysilane (MPS) in an amount of 8 to 16 times the mass of acrylic acid; the solvent is benzene or 2-toluele in an amount of 8 to 16 times the mass of acrylic acid; potassium persulfate is used as initiator; the reaction time is preferably 20 minutes to 80 minutes. According to one embodiment of the present invention, the mass ratio of the surface-modified magnetic Fe3O4 nanoparticles, the potassium persulfate and the acrylic acid monomer is 25-100:1:100.
  • In addition, the alcoholic solvent here is methanol, ethanol or butanol, preferably ethanol, the reaction temperature is preferably 100° C. to 150° C., and the reaction time is preferably 18 hours to 24 hours. The mass ratio of the functional monomer-modified magnetic nanoparticles, the potassium persulfate and the functional monomer is 25-100:1:100.
  • In the process for preparing the nano iron oxide (in step 1), the Fe3O4 nanoparticles are nanoscale ferroferric oxide particles (Fe3O4), MnFe2O4, nanoscale ferric oxide particles (γ-Fe2O3) or other nanoscale ferrite particles, the aqueous ammonia is used as catalyst, the reaction pH is preferably 9 to 10, the reaction time is preferably 20 to 30 minutes, the reaction temperature is between 50-100° C., preferably 70-80° C., the preferred ratio of Fe3+:Fe2+ is 15% to 85%, preferably 1.5:1 to 1:2.5.
  • In addition, in the above process for preparing nanoscale iron oxide (i.e., step 1)), the nanoparticle core is nanoscale ferroferric oxide particles (Fe3O4). Those skilled in the art can understand that it is also possible to use MnFe2O4, nanoscale ferric oxide particles (γ-Fe2O3) or other nanoscale ferrite particles. The aqueous ammonia is used as catalyst, the reaction pH is preferably 9 to 10, the reaction time is preferably 20-30 minutes, the reaction temperature is between 50-100° C., preferably 70-80° C. The preferred ratio of Fe3+:Fe+ is 15% to 85%, preferably 1:2.5 to 1.5:1.
  • In addition, in the above embodiments of the present invention, the agitation in the above reaction system is performed by a magnetic stirrer at a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
  • In addition, in the above embodiments of the present invention, the aqueous ammonia and the liquid monomer are added dropwise continuously and uniformly by an electronic pump at a rate of 20-100 drops/minute, preferably 40-60 drops/minute. Through the use of electronic pump for continuous and uniform dripping, large-scale production can be easily achieved, and the dispersibility and uniformity of nanoparticles can be well controlled.
  • According to a third aspect of the present invention, there is provided a magnetic probe rod system for assisting the removal of stone in urinary system. The magnetic probe rod system comprises a handle 1, a flexible rod 2, a magnetic field source 3, and an optional magnetically permeable material section 4 (in the present invention, the side of the handle is defined as the proximal end of the instrument, and the end of the magnetic field source is defined as the distal end). When an electromagnet is selected as the magnetic field source 3, a switch 11 can be integrated into the handle 1, and the magnetic field power supply can be selected from DC battery, and a battery compartment 12 a and a battery cover 13 a are provided accordingly; when an AC power is selected as the magnetic field power supply, an AC power plug 12 b is provided on the handle correspondingly. When the magnetic field source is an electromagnet, the magnetic field source 3 is composed of an electromagnet core 32 a and an electromagnetic coil 33 a, and externally provided with a magnetic field source encapsulation membrane 31 a made by biocompatible material; when the magnetic field source 3 is a permanent magnet, the magnetic field source 3 is composed of the permanent magnet 32 b and the magnetic field source encapsulation membrane 31 b on its surface; in order to ensure the accessibility of the present invention in human body, a magnetically permeable material section 4 can be optionally disposed at the distal end of the magnetic field source 3, that is, when the electromagnet is used as the magnetic field source, the magnetically permeable material section 4 a can be optionally disposed at the distal end of the electromagnet 3 a, and the magnetically permeable material section is composed of a highly magnetically permeable material 42 a and a magnetically permeable material encapsulating membrane 41 a, in which the highly magnetically permeable material 42 a can be made of an iron-based magnetically permeable material, preferably a pure iron material, and the magnetically permeable material encapsulating membrane 41 a and the magnetic field source encapsulation membrane 31 a can be made of the same material; when the permanent magnet is selected as the magnetic field source, the magnetically permeable material section 4 b may also be disposed at the distal end of the permanent magnet 3 b, composed of the highly permeable material 42 b and the magnetically permeable material encapsulation membrane 41 b, and the magnetically permeable material encapsulation membrane 41 b and the magnetic field source encapsulation membrane 31 b can be made of the same material; when it is not necessary to dispose a magnetically permeable material section at the distal end of the magnetic field source, the system of the present invention is composed of the handle 1, the flexible rod 2 and the magnetic field source 3; for example, when the permanent magnet is selected as the magnetic field source, the magnetic field source at distal end would be composed of a permanent magnet 32 c and an externally disposed magnetic field source encapsulation membrane 31 c; in the above embodiment, the flexible rod 2 may be made of a polymer material such as PU, TPU, PE, PVC, NYLON. PEBAX and silicone rubber, as well as modified materials of the above materials, and the magnetic field source encapsulation membranes 31 a, 31 b and 31 c as well as the magnetically permeable material encapsulation membranes 41 a and 41 b are all made of the same material as the flexible rods.
  • Further, the present invention provides an article comprising the magnetic nanoparticle, in which the magnetic nanoparticle is further processed to form a stone-removing solution (using physiological saline, buffer as solvent) or a stone-removing powder, preferably a stone-removing solution, which is used as a medical clinical article.
  • The basic principle of the high performance system for removing a stone in urinary system, which consists of the functional magnetic nanoparticle and the magnetic probe rod as shown, is achieved by the following steps: 1) pulverization of stones in vivo; 2) injection of the functional magnetic nanoparticles, the magnetic nanoparticles having excellent dispersibility (dispersibility and dispersion coefficient are related, the smaller the dispersion coefficient, the better the dispersibility); 3) interaction between the functional magnetic nanoparticles and the stones; 4) surrounding the stones with the functional magnetic nanoparticles (wherein, the surrounding stones is closely related to the dispersibility of the magnetic particles, the better the dispersibility and the better the effect of the surrounding stones); 5) physical or chemical crosslinking of the magnetic nanoparticles on the surface of the stones; 6) removal of the magnetized stones under the guidance of an external magnetic field (wherein, the effect of removing stones by guide is closely related to the effect of surrounding the stones, the better the effect of surrounding the stones, the better the effect of removing the stones). The stones are surrounded and magnetized by the magnetic nanoparticles via physical adsorption, chemical bonding and the like. The physical adsorption mainly refers to an attraction generated by van der Waal's force and hydrophobic interaction within the range of action between hydrophobic magnetic particles—particles and between particles—stones, so that the surface of the stones are adsorbed and surrounded by the magnetic particles; the chemical bonding mainly refers to the interaction between the hydrophilic magnetic nanoparticles—particles and between particles—stones mainly through the formation of chemical bonds (chemical bonds, such as hydrogen bonds, covalent bonds, etc., between carboxyl on the surface of the particles and the stones), so that the surface of the stones is surrounded with the magnetic particles; the chemical bonding includes: the functional magnetic nanoparticles (such as photosensitive, thermosensitive nanoparticles, etc.) firstly act on the stones via physical adsorption, and then further enhance the mutual force between particles—particles and particles—stones via photosensitive crosslinking, thermosensitive physical entanglement (crosslinking) and the like to surround the stones. The principle of the above interaction is shown in FIG. 15. In addition, during the modification process of the nanoparticles by the surface-modifier monomer, the dropping manner of the monomer for the surface-modifier monomer or the weight percentage of the shell formed by the monomer of the surface-modifier with regard to the nanoparticle has significant influences on the dispersibility, as shown in FIGS. 18-21.
  • The followings are detailed examples of the structure, preparation and use of the magnetic nanoparticles of the present invention.
  • Example 1: Preparation of Magnetic Nanoparticle Core
  • 1. Preparation of 10 nm Fe3O4 by Co-Precipitation Method
  • 3.05 g FeCl3.6H2O and 2.08 g FeCl2.4H2O (molar ratio 1:1) were dissolved in 50 ml deionized water in a three-necked flask. Nitrogen gas was used throughout the experiment. Aqueous ammonia was added dropwise with a syringe and stirred vigorously at room temperature to adjust pH to 9, the solution gradually turned from yellow to brown and finally black, and the reaction was carried out for 20 minutes. After the reaction, the solution was placed in a 70° C. water bath and incubated for 20 minutes, stirred vigorously to remove excess ammonia. The three-necked flask was taken out and allowed to cool to room temperature under vigorous agitation. The suspension of the synthesized Fe3O4 magnetic particles was poured into a 50 ml centrifuge tube, a powerful magnet was used to attract the magnetic particles, liquid waste was discarded, deionized water was added, the magnetic particles were re-suspended under ultrasonic, so repeatedly to wash away excess ammonia until pH showed neutral. The collected magnetic particles were placed in an oven at 65° C. to be dried and dewatered. The synthesized magnetic particles were weighed, and 1.0 ml suspension of 0.02 mg/ml magnetic particles was formulated for measurement of particle size. A total of 1.5 ml of 0.02M sodium oleate solution was added dropwise to 1.0 ml suspension of 0.2 mg/ml magnetic particles, reacted at 70° C. under nitrogen and vigorous agitation for 30 minutes, and then cooled to room temperature. Excess sodium oleate was removed by dialysis using 12 KD dialysis membrane. Thus, 1.0 ml of 0.02 mg/ml sodium oleate-encapsulated Fe3O4 solution was formulated, and its particle size was measured.
  • 2. Preparation of Fe3O4 Magnetic Nanoparticle Core
  • 2.1 Thermal Decomposition Method
  • 2.1.1 Synthesis of 4 nm Fe3O4 Seeds:
  • 5 mmol of ferric triacetylacetonate, 5 mmol of 1,2-dihydroxyhexadecane, 3 mmol of oleic acid, 1 mmol of oleylamine were dissolved in 20 ml of diphenyl ether and magnetically stirred under a nitrogen atmosphere. The above mixture was stirred at 200° C. for 30 minutes, and then heated under reflux for 30 minutes at 265° C. under the protection of nitrogen gas. The heating was stopped, and the dark brown liquid mixture obtained from the reaction was cooled to room temperature under atmospheric conditions, 400 ml of ethanol was added, and the resulting black material was separated by overspeed centrifugation. The black product obtained by centrifugation was redissolved in n-hexane containing 50 μL of oleic acid and 50 μL of oleylamine, centrifuged at 600 rpm for 10 minutes to remove insoluble residues. The resulting 4 nm Fe3O4 product was precipitated with ethanol, centrifuged at 600 rpm for 10 minutes to remove solvent and then redispersed into n-hexane. The following different methods were used respectively to synthesize surface-functionalized nanoparticles with different sizes.
  • 2.1.2 Synthesis of 6 nm Fe3O4 Nanoparticle Core Using 4 nm Fe3O4 Seeds
  • 20 mmol of ferric triacetylacetonate, 10 mmol of 1,2-dihydroxyhexadecane, 6 mmol of oleic acid and 6 mmol of oleylamine were dissolved in 20 ml of diphenyl ether and magnetically stirred under a nitrogen atmosphere. The above mixture was heated at 200° C. for 2 hours, and then heated under reflux for 1 h at 300° C. under the protection of nitrogen gas. The heating was stopped, and the dark brown liquid mixture obtained from the reaction was cooled to room temperature. The aforementioned operation steps for the synthesis of the 4 nm Fe3O4 particles were adopted to obtain a black brown suspension of 6 nm Fe3O4 particles dispersed in n-hexane.
  • 2.1.3 Synthesis of 8 nm Fe3O4 Nanoparticle Core Using 6 nm Fe3O4 Seeds
  • 2 mmol of ferric triacetylacetonate, 10 mmol of 1,2-dihydroxyhexadecane, 2 mmol of oleic acid and 2 mmol of oleylamine were dissolved in 20 ml of ethyl ether and magnetically stirred under nitrogen protection. 84 mg of 6 nm Fe3O4 particles were weighed, dissolved in 4 ml of n-hexane, and then added to the above mixture liquid. The above mixture liquid was first heated at 100° C. for 30 minutes to remove n-hexane, then heated at 200° C. for 1 hour, and heated under reflux at 300° C. for 30 minutes under nitrogen protection. The heating was stopped, and the black mixture liquid resulting from the reaction was allowed to cool to room temperature. The aforementioned synthesis steps for 4 nm Fe3O4 particles was used to give a dark brown suspension of 8 nm Fe3O4 particles dispersed in n-hexane. Similarly, 80 mg of 8 nm Fe3O4 seeds reacted with 2 mmol of ferric triacetylacetonate and 10 mmol of 1,2-dihydroxyhexadecane to produce 10 nm Fe3O4 nanoparticles. Using this Fe3O4 seed-mediated growth method, Fe3O4 nanoparticles with larger size (up to 20 nm) could be synthesized.
  • 2.1.4. Surface Modification of Fe3O4 Nanoparticle Core
  • Under atmospheric conditions, 200 μl of n-hexane solvent with 20 mg of dispersed hydrophobic Fe3O4 nanoparticle core was added to 2 ml of dichloromethane suspension containing 20 mg of tetramethylammonium salt of 1-aminoundecanoic acid. The mixture was shaken for 20 minutes, while a magnet was used to separate the precipitated Fe3O4 nanoparticles. The solvent and the non-magnetic suspended matter were decanted, the resulting precipitate was washed once with dichloromethane, and then the separation with magnet was performed again to remove excess surfactant. The resulting product was dried under nitrogen gas and then dispersed in deionized water or pH-neutral PBS.
  • 2.2 Hydrothermal Synthesis Method
  • 1.35 g (5 mmol) of ferric chloride hexahydrate (FeCl3.6H2O) was dissolved in 40 mL of ethylene glycol to form a clear solution. To the above solution, 3.6 g of sodium acetate and 1.0 g of polyethylene glycol were added, stirred vigorously for 30 minutes, and then transferred to a 50 ml sealed stainless steel autoclave, reacted at 200° C. for 8-72 hours, and then cooled to room temperature. The black product obtained in the reaction was washed with ethanol for several times and then dried at 60° C. for 6 hours, to obtain a magnetic nanoparticle core having a particle diameter of 10 nm or less.
  • 2.3 Microemulsion Method (Reverse Micellar Method)
  • 5 mmol of Mn(NO3)3 and 10 mmol of Fe(NO3)3 were dissolved in 25 mL of deionized water to form a clear and transparent solution; 25 mL of 0.4 M NaDBS ([CH3(CH2)11(C6H4)SO3]Na) was added to the above iron ion solution, and then added with a large volume of toluene, in which the particle size of the resulting MnFe2O4 nanoparticles depended on the volume ratio of water and toluene. For example, in order to obtain 8 nm nanoparticles, the volume ratio of water and toluene should be 5:100. After the above mixture liquid was stirred overnight, it became a clear single-phase solution containing reversed micelles.
  • In order to form colloids in the reversed micelles, 40 mL of 1 M NaOH solution was added dropwise with vigorous stirring, and the stirring was continued for 2 hours. The water and most of the toluene in the solution were removed by distillation to reduce the volume of the solution. The resulting concentrated solution containing suspended colloids was washed with water and ethanol to remove excess surfactant in the solution. A primary magnetic nanoparticle core was obtained by ultracentrifugation, and a nanocrystal was obtained by heating at 350° C. under nitrogen atmosphere for 12 hours.
  • Example 2: Hydrophobic Polystyrene Surface Modification
  • (Modification on the Magnetic Nanoparticle Core (MnFe2O4) Obtained in Example 1)
  • MnFe2O4 nanoparticles with an average particle size of 9 nm were added to an aqueous solution/3-chloropropionic acid solution with a concentration of 1.0 mol/L initiator, the solution was adjusted to pH of 4 with hydrochloric acid, and stirred overnight. The nanoparticles were collected with a magnet, washed with water for several times to remove excess 3-chloropropionic acid. 0.22 g of dried nanoparticles were added to 8 mL of polystyrene solution under continuous feeding of nitrogen gas, followed by the addition of 4 mL of an xylene solution of 0.3 mmol of CuCl and 1.1 mmol of 4,4′-dinonyl-2,2-dipyridine. The above mixture reacted at 130° C. for 24 h under continuous agitation. The nanoparticles were collected with a magnet and washed repeatedly with toluene to obtain polystyrene-surrounded magnetic iron oxide nanoparticles.
  • Example 3: Hydrophilic Polyacrylic Acid Modification
  • 1 g of Fe3O4 obtained in Example 1 (for example, 10 nm Fe3O4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out under stirring at 80° C. for 3 hours. After the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe3O4, and vacuum-dried for 12 hours. The above-mentioned silane coupling agent-activated Fe3O4, 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, reacted under under nitrogen protection and stirring at 40° C. for 10 minutes. Then, 4 ml of acrylic acid was slowly dropped into the flask, and reacted under nitrogen protection and stirring al 3) 40° C. for 1 hour. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried under vacuum.
  • Example 4: Photosensitive Functional Modification of Nanoparticles
  • 1. Synthesis of Photosensitive Functional Monomer
  • The synthesis method of photosensitive monomer with photo-crosslinking characteristics comprised: 4-vinylbenzophenone (4VBP) and styrene monomer were directly polymerized by atom transfer radical polymerization (ATRP) to obtain a photosensitive polystyrene-polyvinylbenzophenone copolymer (PS-PVBP), wherein the specific steps were as follows: in a dry Schlenk tube connected with a reflux condenser, Cu(I)Br (0.695 mg, 4.8 umol), 4VBP (1.0 g, 4.8 mmol), styrene (2 u, 20 umol) and 4-vinylbenzophenone (1 μL, 4.8 umol) were added, and the mixture was degassed for three times by means of freeze-pump-thaw circulation. Methyl bromopropionate (5.35 μL, 48 umol) was added to the above mixture at −78° C. under condition of nitrogen with positive pressure, and the mixture was degassed again for three more times by means of freeze-pump-thaw circulation. Polymerization was carried out by heating the mixture to a temperature of 85° C. under negative pressure, and the reaction was allowed to proceed for 4 hours. The above Schlenk tube was immersed in liquid nitrogen, and 10 ml of dichloromethane was added to dissolve the polymer. The resulting solution was precipitated twice with methanol (2×300 mL) to give PSx-PVBPy as a light yellow solid, wherein x: y˜(60%-90%), and a preferred composition was PS75-PVBP25. In the same way, PS75-PVBP25-PAA100 could be obtained by adding hydrophilic monomer acrylic acid.
  • 2. Preparation of Nanoparticles Surrounded with Photosensitive Cross-Linked Micelles
  • (Polystyrene75-co-polyvinylbenzophenone25)-polyacrylic acid100, namely (PS75-co-PVBP25)115-b-PAA100, was chosen as a polymer to form micelles in aqueous solution. 5 mg of (PS75-co-PVBP52)115-b-PAA100 and 10 mg of Fe3O4 obtained in Example 1 (for example, 10 nm Fe3O4 obtained by co-precipitation method) were dissolved in 10 ml of dimethylformamide (DMF) solution; and then double distilled water (0.1 ml/min) was gradually added under vigorous stirring. When the volume of water reached 60%, the resulting solution was added to a dialysis membrane with a molecular weight cut off of 12K-14K and dialyzed against water for 24 hour to remove DMF, and then the micellar solution was transferred to a quartz tube and irradiated with a laser at different time periods (emission wavelength: 315-400 nm) to form a photosensitive monomer-surrounded nanoparticle.
  • Example 5: Thermosensitive Functional Modification of Nanoparticles
  • 1 g of Fe3O4 obtained in Example 1 (for example, 10 nm Fe3O4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out with stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe3O4, and vacuum-dried for 12 hours. The above-mentioned silane coupling agent-activated Fe3O4, 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, reacted under nitrogen protection and stirring at 40° C. for 10 minutes. Then, 4 ml of N-isopropylacrylamide aqueous solution was slowly dropped into the flask, and reacted under nitrogen protection and stirring at 40° C. for 1 hour. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried in vacuo.
  • Example 6: pH-Sensitive Functional Modifications of Nanoparticles
  • 1 g of Fe3O4 obtained in Example 1 (for example, 10 nm Fe3O4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH1570) were mixed with 50 ml of xylene in a reaction flask, and reacted under nitrogen protection and stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe3O4, and dried in vacuo for 12 hours. The above-mentioned silane coupling agent-activated Fe3O4, 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, reacted under nitrogen protection and stirring at 40° C. for 10 minutes. Then, 4 ml of dimethylaminoethyl methacrylate aqueous solution was slowly dropped into the flask, and reacted at 40° C. for 1 hour under stirring and nitrogen protection. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried in vacuo.
  • Example 7: Biocompatibility Evaluation
  • Cell Plating: 293t cells in logarithmic growth phase were digested, counted after centrifugation, and plated on a 96-well plate with a cell density of 5.0×104/well. 100 μl of serum-containing medium was added to each well. The surrounding blank wells were each complemented with 100 μl of serum-containing medium. The plate was placed in a 7% CO2, 37° C. cell incubator overnight. The hydrophilically modified magnetic nanoparticles of Example 3 in an amount of 100 μl per well were added to the cell wells and incubated with N87 cells, wherein the magnetic nanoparticles obtained in Example 3 was used in concentrations of 0.1, 0.2, 0.4, 0.8, 1.0 mg/ml respectively. After incubated at 37° C. for 24 hours, the cells were gently washed twice with culture medium, and then the cell viability was measured with a Cell Counting Kit-8 kit, in which the detection conditions were as follows: 10 μl of CCK-8 reagent per well, incubate at 37° C. for 2 hours, read the absorbance value at 450 nm with BIO-TEK ELx800 automatic microplate reader, and calculate the cell viability. The results shown in FIG. 5, indicating the synthesized hydrophilically modified magnetic nanoparticles had good biocompatibility and almost no toxicity in vivo, and giving preliminary evidences of applicability for in vivo experiments.
  • Example 8: Evaluation of In Vitro Stone Separation with Assistance of Nanoparticles
  • As shown in FIG. 6, a certain amount of stones were weighed, pulverized with a pestle into a powder (particle size 0.5-2 mm), poured into a transparent glass bottle, and PBS solution was added to obtain a stone liquid. After being mixed uniformly, the hydrophilically modified magnetic particles of Example 3 at a concentration of 1 mg/ml was used as a separation liquid and added, and then gently shaken. After standing for 5 minutes, separation was carried out with a magnet. During standing, it was observed that the color of the mixture gradually faded, and after 5 minutes, it was observed that the black magnetic particles were adsorbed on the surface of the stone. Under the guidance of the magnetic field, the stones with magnetic particles adsorbed on their surface moved toward the magnet.
  • Example 9: Evaluation of In Vive Safety of Nanoparticles in Animals
  • As shown in FIG. 7, one 6-week-old nude rat and 3 mice were intraperitoneally injected and tail vein injected, respectively. The hydrophilically modified magnetic nanoparticles of Example 3 at a concentration of 0.5 mg/ml and in an amount of 200 μL were used for the injection for consecutive two days. The living conditions of the mice were observed periodically (such as one week, two weeks, etc.). The results showed that after intravenous injection of 200 μL of magnetic nanoparticle solution, no obvious toxicity was found in the nude rat and the mice within 1 week; and after intraperitoneal injection of particle solution at the same concentration 3 times, it was found that the rat and the mice had good survival status within 3 months. This shows that the prepared magnetic nanoparticles have good biocompatibility, and such preliminary assessment shows they basically have no acute toxicity and chronic toxicity.
  • Example 10: Using Magnetic Nanoparticles in Removal of Urinary Stones
  • In the treatment of disease of kidney stones, an ureteroscope was used for holmium laser lithotripsy. In the operation, after crushing process of kidney stones with holmium laser, 200 ml of the hydrophilic magnetic nanoparticle solution of Example 3 according to the present invention was injected into the kidney through the working channel of the ureteroscope, so that the hydrophilic magnetic nanoparticle solution was thoroughly mixed with the stone debris. After about 3 minutes, the nanoparticles in the solution completely adhered to the surface of the stone debris, and magnetized the stone debris. The above-mentioned magnetic probe rod system for removal of stones in urinary system, in which a NdFeB permanent magnet was used as the magnetic field source 3, was inserted into the kidney through the working channel of the ureteroscope. Under the action of the magnetic field at the distal end of the magnetic probe rod system, the magnetized stone debris moved closer to the distal end of the magnetic probe rod and attracted to the magnetic probe rod. Finally, the magnetic probe rod system filled with stones debris at its distal end together with the ureteroscope were drawn from the body through the soft sheath of the ureteroscope. After the the stone debris were removed from the distal end of the magnetic probe rod, the magnetic probe rod could be inserted again into the endoscope to carry out stone removal operation, until all of the stone debris inside the kidney were removed from the body. In this Example, the stone had a diameter of about 20 mm and was located in the lower kidney calyx. By using the magnetic probe rod system in combination with the hydrophilic magnetic nanoparticle material of the present invention, all (100%) of the stone debris were removed from the body. In comparison with the traditional method of removing stones by baskets and the method of pulverizing stones and then allowing patients to discharge stone debris, the technical solutions of the present invention achieved simple, efficient and complete removal of stones, thereby greatly improving the efficiency and safety of stone removal operations.
  • Example 11: Effect of the Mode of Dropping Surface Modifier Monomer on the Dispersibility of Magnetic Nanoparticles
  • 1 g of Fe3O4 obtained in Example 1 (for example, 10 nm Fe3O4 obtained by co-precipitation method), 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out under stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe3O4, and vacuum-dried for 12 hours. The above-mentioned silane coupling agent-activated Fe3O4, 40 mg of potassium persulfate and 30 ml of deionized water were added in the flask, stirred and reacted under protection at 40° C. for 10 minutes.
  • In order to compare the influence of the mode of dropping the surface modifier monomer (taking acrylic acid as the representative) on the particle dispersibility of the final magnetic nanoparticles, the experiments were carried out to systematically compare the dropping group (manual and gradual dropping of acrylic acid surface-modifier monomer) and the continuous addition group (electronic and continuous dropping of acrylic surface-modifier monomer). In the dropping group, 4 ml of acrylic acid for manual and gradual dropping was gradually dropped (every 3 seconds) by hand using an injection syringe into the flask, and the reaction was carried out under nitrogen protection and stirring at 40° C. for 1 hour. In the continuous addition group, 4 ml of acrylic acid for electronic and continuous dropping was added dropwise and uninterruptedly by an electronic pump at the designed speed to the flask, and the reaction was carried out under nitrogen protection and stirring at 40° C. for 1 hour. Finally, the nanoparticles were magnetically separated, washed three times with deionized water and finally dried under vacuum.
  • Using the German ALV-CGS3 static and dynamic laser light scattering instrument, the monodispersity coefficient of the magnetic nanoparticles was measured, and the specific experimental results were shown in FIG. 18. It can be seen from FIG. 18 that, in comparison with the monodispersity coefficient (0.478±0.075) of the magnetic nanoparticles of the dropping group, the monodispersity coefficient (0.0043±0.0016) of the magnetic nanoparticles of the continuous addition group was far lower, that is, the magnetic nanoparticles obtained in the continuous addition group have better dispersibility.
  • Further, it can be seen from FIGS. 19-20 that the dispersibility of the magnetic nanoparticles of the continuous addition group was better than that of the magnetic nanoparticles of the dropping group.
  • Example 12: Effect of the Weight Percentage of the Nanoparticle Shell with Regard to the Nanoparticles on the Dispersibility of the Nanoparticles
  • 1 g of Fe3O4 obtained in Example 1 (for example, 10 nm Fe3O4 obtained by co-precipitation method) and 5 ml of a silane coupling agent (methacryloxypropyltrimethoxysilane, KH570) were mixed with 50 ml of xylene in a reaction flask. Under nitrogen protection, the reaction was carried out under stirring at 80° C. for 3 hours. After the completion of the reaction, the mixture was centrifuged and washed with ethanol three times to remove the silane coupling agent adsorbed on the surface of the Fe3O4, and vacuum-dried for 12 hours. The above-mentioned silane coupling agent-activated Fe3O4, 40 mg of potassium persulfate and 30 ml of deionized water were added in a flask, stirred and reacted at 40° C. for 10 minutes under protection of nitrogen atmosphere.
  • In order to compare the influence of the weight percentage of the shell formed by the surface-modifier monomer (taking acrylic acid as representative) on the surface of the nanoparticles on the dispersibility of the final particles, the nanoparticle dispersibilities of the nanoparticles of the following 6 groups were systematically compared: Group 1 (the weight percentage of the shell is 0.5%, with regard to the weight of the particles), Group 2 (the weight percentage of the shell is 1%, with regard to the weight of the particles), Group 3 (the weight percentage of the shell is 2%, with regard to the weight of the particles), Group 4 (the weight percentage of the shell is 15%, with regard to the weight of the particles), Group 5 (the weight percentage of the shell is 40%, with regard to the weight of the particles) and Group 6 (the weight percentage of the shell is 45%, with regard to the weight of the particles). In the experiment, the aqueous solution of acrylic acid for each of the weight percentage groups was slowly dropped into the flask, and reacted under nitrogen protection and stirring at 40° C. for 1 hour. The nanoparticles were magnetically separated, washed three times with deionized water and finally dried in vacuo.
  • The monodispersity coefficient of the magnetic nanoparticles was measured by the German ALV-CGS3 dynamic and static laser light scattering instrument, and the specific experimental results were as follows: the monodispersity coefficient of the nanoparticles of Group 1 was 0.5±0.04; the monodispersity coefficient of the nanoparticles of Group 2 was 0.026±0.0026; the monodispersity coefficient of the nanoparticles of Group 3 was 0.036±0.003; the monodispersity coefficient of the nanoparticles of Group 4 was 0.022±0.002; the monodispersity coefficient of the nanoparticles of Group 5 was 0.031±0.0028; the monodispersity coefficient of the nanoparticles of Group 6 was 0.58±0.05.
  • The above experimental results show that, compared with the monodispersity coefficients of the nanoparticles in the groups (Groups 1 and 6) wherein the shell weight percentages were 0.5% and 45% with regard to the nanoparticles, respectively, the monodispersity coefficients of the nanoparticles in the groups (Groups 2, 3, 4 and 5) wherein the shell weight percentages were 1%, 2%, 15% and 40% with regard to the nanoparticles were much lower (see FIG. 21), that is, the nanoparticles of Groups 2, 3, 4 and 5 have better dispersibility.
  • While many embodiments of the invention have been shown and/or discussed herein, it is not intended that the invention is limited thereto. It is anticipated that the scope of the present invention will be the same as what is allowed in the art, and equally appreciated according to the description. Therefore, the above description should not be construed as limiting, but merely as exemplifications of specific embodiments. Those skilled in the art can envision other variations within the scope and spirit of the claims appended hereto.

Claims (20)

What is claimed:
1. A nanoparticle, the nanoparticle comprises:
a nanoparticle core made of a magnetic material; and
a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent;
wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the weight percentage of shell is 0.5-45% (excluding end points), with regard to the weight of the nanoparticle.
2. The nanoparticle according to claim 1, wherein the weight percentage of shell is 1-40%, more preferably 2-40%, further more preferably 1-15%, much further more preferably 2-15%, most preferably 1%, 2%, 15% or 40%, with regard to the weight of the nanoparticle.
3. The nanoparticle according to claim 1, wherein the nanoparticle core has a diameter of 2-50 nm, and a weight percentage of 30-95% with regard to the whole weight of the nanoparticle, and its magnetic material includes a compound of Fe3+, Fe2+, Mn2+, Ni2+, or a metal element selected from iron, nickel, copper, cobalt, platinum, gold, europium, gadolinium, dysprosium, terbium, or a composite or oxide of the aforementioned metals, or any one of the above items or a combination of two or more of the above items, preferably Fe3+, Fe2+, Mn2+, Ni2+ compounds, more preferably Fe3+ and Fe2+ in a ratio of 15% to 85%, preferably 1:2.5 to 1.5:1.
4. The nanoparticle according to any one of claims 1-3, wherein the surface modifier includes a hydrophilic surface modifier, a hydrophobic surface modifier, a photosensitive, a thermosensitive surface modifier or a pH sensitive surface modifier with function response, wherein the hydrophilic surface modifier includes acrylic acid, methacrylic acid, isobutyl acrylamide or poly N-substituted isopropylacrylamide; the hydrophobic surface modifier includes olefins, preferably polystyrene, polyethylene or oleic acid; the photosensitive surface modifier is selected from the group consisting of azos and quinolines and benzophenones (PVBP), preferably vinyl benzophenone; the thermosensitive surface modifier is selected from the group consisting of amphiphilic polymers with an amide bond, preferably polyacrylamide or poly N-substituted isopropylacrylamide; the pH-sensitive surface modifier is selected from the group consisting of polymers with a carboxyl group and a quaternary ammonium salt, preferably polyacrylic acid, dimethylaminoethyl ester and dimethylaminopropyl methacrylate; the particle is of spherical shape, rod shape or diamond shape.
5. The nanoparticle according to any one of claims 1-3, wherein the crosslinking agent includes 3-(methacryloyloxy)propyltriethoxysilane, divinylbenzene, diisocyanate or N,N-methylenebisacrylamide, and the initiator includes 3-chloropropionic acid, CuCl, 4,4′-dinonyl-2,2-bipyridine or potassium persulfate.
6. A nanoparticle, the nanoparticle comprises:
a nanoparticle core made of a magnetic material; and
a nanoparticle shell formed by in-situ modification of a surface modifier monomer to the surface of the nanoparticle core with an initiator and/or a crosslinking agent;
wherein the surface of the nanoparticle after surface modification and functionalization has an amide bond or a carboxyl group, and the method for preparing the magnetic nanoparticle core is co-precipitation method, wherein the mode of adding the surface modifier monomer is a continuous dropping with assistance of an electronic pump.
7. The nanoparticle according to claim 6, wherein the nanoparticle core has a diameter of 2-50 nm, and a weight percentage of 30-95% with regard to the whole weight of the nanoparticle, and its magnetic material includes a compound of Fe3+, Fe2+, Mn2+, Ni2+, or a metal element selected from iron, nickel, copper, cobalt, platinum, gold, europium, gadolinium, dysprosium, terbium, or a composite or oxide of the aforementioned metals, or any one of the above items or a combination of two or more of the above items, preferably Fe3+, Fe2+, Mn2+, Ni2+ compounds, more preferably Fe3+ and Fe2+ in a ratio of 15% to 85%, preferably 1:2.5 to 1.5:1.
8. The nanoparticle according to claim 7, wherein the mutual forces for surrounding and crosslinking between the nanoparticles and the stone include: van der Waal's force that form an interacting surrounding, hydrophobic interaction, adsorption and surface deposition; chemical bonds formed between carboxyl-stone, including hydrogen bonds, ester bonds, amide bonds and other covalent bonds; interacting physical and chemical entanglements between chains and chemical crosslinking between chains.
9. The nanoparticle according to any one of claims 6-8, wherein the surface modifier includes a hydrophilic surface modifier with function response, a hydrophobic surface modifier with function response, a photosensitive surface modifier with function response, a thermosensitive surface modifier with function response or a pH sensitive surface modifier with function response, wherein the hydrophilic surface modifier includes acrylic acid, methacrylic acid, isobutyl acrylamide or poly N-substituted isopropylacrylamide; the hydrophobic surface modifier includes olefins, preferably polystyrene, polyethylene or oleic acid; the photosensitive surface modifier is selected from the group consisting of azos and quinolines and benzophenones (PVBP), preferably vinyl benzophenone; the thermosensitive surface modifier is selected from the group consisting of amphiphilic polymers with an amide bond, preferably polyacrylamide or poly N-substituted isopropylacrylamide; the pH-sensitive surface modifier is selected from the group consisting of polymers with a carboxyl group and a quaternary ammonium salt, preferably polyacrylic acid, dimethylaminoethyl ester and dimethylaminopropyl methacrylate; the shell accounts for 0.5-45% by weight (excluding end points) of the nanoparticle, preferably 1-40%, more preferably 2-40%, further more preferably 1-15% or 2-15%, most preferably 1%, 2%, 15% or 40%; preferably, the particle is of spherical shape, rod shape or diamond shape.
10. The nanoparticle according to any one of claims 6-9, wherein the crosslinking agent includes 3-(methacryloyloxy)propyltriethoxysilane, divinylbenzene, diisocyanate or N,N-methylenebisacrylamide, and the initiator includes 3-chloropropionic acid, CuCl, 4,4′-dinonyl-2,2-bipyridine or potassium persulfate.
11. A method for preparing the nanoparticle according to any one of claims 1-10, wherein said method includes the following steps:
a) preparing the nanoparticle core using the magnetic material;
b) forming the nanoparticle shell by in-situ linking the surface modifier monomer to the nanoparticle core by the initiator and/or crosslinking agent, thereby forming the nanoparticle.
12. The method according to claim 11, wherein the magnetic material includes a compound of Fe3+, Fe2+, Mn2+, Ni2+, or a metal element selected from iron, nickel, copper, cobalt, platinum, gold, europium, gadolinium, dysprosium, terbium, or a composite or oxide of the aforementioned metals, or any one of the above items or a combination of two or more of the above items, preferably Fe3O4, MnFe2O4, γ-Fe2O3 or other nanoscale sized ferrite particles, more preferably FeCl3.6H2O and FeCl2.4H2O in a molar ratio of 15% to 85%, preferably 1:2.5 to 1.5:1, including the following steps:
dissolving a proportion of the metal salt-containing material in water;
feeding nitrogen to expel oxygen in the solution;
adding a catalyst at a room temperature of 10-40° C., preferably 30° C., to adjust the pH to 7-12, preferably 10;
keeping agitation and reaction for 10-60 minutes; and
reacting under condition of 40-100° C., preferably 70° C. water bath, for 20-40 minutes, then separating with a magnet and drying to obtain the magnetic nanoparticle core.
13. The method according to claim 12, wherein when aqueous ammonia is used as the catalyst to prepare the nanoparticle, the method for dropping the aqueous ammonia is performed in a continuous and dropwise manner with assistance of an electronic pump at a speed of 20-100 drops/minute, preferably 40-60 drops/minute; and when the magnetic material is a liquid monomer material, the liquid monomer is added in a dropwise and continuous manner with assistance of an electronic pump, and the reaction is carried out under agitation with a speed of 100-1000 revolutions/minute, preferably 500-700 revolutions/minute.
14. The method according to any one of claims 11-13, wherein said method further includes hydrophobic surface modification based on the obtained nanoparticle core, including steps of:
dispersing the prepared nanoparticle core in an aqueous solution, and adding with an xylene solution of 3-chloropropionic acid, polystyrene, CuCl and 4,4′-dinonyl-2,2-bipyridine, wherein the molar ratio between the solution of the nanoparticle core and the reaction solution is 1:1;
reacting the mixture at 130° C. under continuous agitation for 15-30 hours, preferably 24 hours; and
collecting the nanoparticles with a magnet, washing repeatedly with toluene to obtain hydrophobic polystyrene-surrounded magnetic iron oxide nanoparticles.
15. The method according to any one of claims 11-13, wherein said method further includes hydrophilic surface modification based on the obtained nanoparticle core, including steps of:
dispersing the prepared nanoparticle core in xylene, and added with a silane coupling agent, wherein the nanoparticles, xylene and silane coupling agent are added in a ratio of 95:5;
reacting under nitrogen protection at 20-100° C., preferably at 80° C., for 2-5 hours, preferably for 3 hours;
washing with an alcoholic solvent and drying for 12 hours, dispersing in an aqueous solution under ultrasonic condition, adding with potassium persulfate;
reacting under nitrogen protection at 40-80° C. for 10 minutes, then adding with acrylic acid to continue reaction at 40-80° C. for 1 hour, preferably at the reaction temperature of 70° C.; and
magnetically separating, washing and drying to obtain the polyacrylic acid-modified hydrophilic nanoparticle.
16. The method according to any one of claims 11-13, wherein said method further includes performing a photosensitive, thermosensitive and pH-sensitive surface modification based on the resulting nanoparticle core or on a hydrophilic surface thereof, or performing a hydrophilic, hydrophobic, light-sensitive, thermosensitive, pH-sensitive co-modification based on the nanoparticle core, wherein the re-modification on the hydrophilic surface includes the steps of:
dissolving and dispersing the polyacrylic acid-modified magnetic nanoparticle in an alcoholic solvent, adding with a photosensitive monomer such as vinylbenzophenone, a thermosensitive monomer such as N-isopropylacrylamide, or a pH-sensitive monomer such as dimethylaminopropyl methacrylate or a blend monomer of acrylic acid and styrene, continuously reacting at 40-80° C. for 1 hour, preferably at a reaction temperature of 70° C.; and magnetically separating, washing and drying to obtain a photosensitive, thermosensitive or pH-Sensitive functional monomer-modified magnetic nanoparticle.
17. A stone removal device, comprising the nanoparticle according to any one of claims 1-10, and a magnetic probe rod system with an flexible end, wherein the magnetic probe rod system comprises a handle, a flexible rod, a magnetic field source and a magnetically permeable material.
18. The stone removal device according to claim 17, wherein the magnetic probe rod system is provided with an AC or DC power supply, a power switch, a DC battery compartment or an AC plug on the handle; the flexible rod is made of a polymer material, preferably the flexible rod includes a permanent magnet at its rear end and optionally a flexible magnetically permeable material at the end of the flexible rod.
19. An article, the article comprising the nanoparticle according to any one of claims 1-10, wherein the nanoparticle is in form of a solution or a powder, preferably a solution.
20. A use of the nanoparticle according to any one of claims 1 to 10 in the manufacture of an article for in-vivo stone removal, preferably the article is used for urinary stone removal in a human or animal.
US15/763,625 2015-09-29 2016-09-29 Nanoparticles and preparation method thereof Abandoned US20180289866A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510631394.5A CN106552296B (en) 2015-09-29 2015-09-29 Nano particles, preparation method thereof, calculus removing device and application
CN201510631394.5 2015-09-29
PCT/CN2016/100782 WO2017054750A1 (en) 2015-09-29 2016-09-29 Nanoparticle and preparation method therefor

Publications (1)

Publication Number Publication Date
US20180289866A1 true US20180289866A1 (en) 2018-10-11

Family

ID=58416862

Family Applications (3)

Application Number Title Priority Date Filing Date
US15/763,639 Active 2038-03-16 US11331417B2 (en) 2015-09-29 2016-09-26 Magnetic target separation instrument and application thereof
US15/763,611 Abandoned US20180271609A1 (en) 2015-09-29 2016-09-29 Use of a magnetic material in removal of stones
US15/763,625 Abandoned US20180289866A1 (en) 2015-09-29 2016-09-29 Nanoparticles and preparation method thereof

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US15/763,639 Active 2038-03-16 US11331417B2 (en) 2015-09-29 2016-09-26 Magnetic target separation instrument and application thereof
US15/763,611 Abandoned US20180271609A1 (en) 2015-09-29 2016-09-29 Use of a magnetic material in removal of stones

Country Status (7)

Country Link
US (3) US11331417B2 (en)
EP (3) EP3357521A4 (en)
JP (3) JP6719565B2 (en)
KR (3) KR102164560B1 (en)
CN (4) CN106552296B (en)
RU (3) RU2727236C1 (en)
WO (3) WO2017054750A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106552296B (en) 2015-09-29 2020-08-14 上海氪励铵勤科技发展有限公司 Nano particles, preparation method thereof, calculus removing device and application
CN107008922B (en) * 2017-04-20 2019-06-28 郑州航空工业管理学院 A kind of magnetic metal Co nano-powder and preparation method thereof
RU2684325C1 (en) * 2018-05-03 2019-04-08 Федеральное государственное бюджетное учреждение науки Пермский федеральный исследовательский центр Уральского отделения Российской академии наук ("ПФИЦ УрО РАН") Method of producing conjugate based on magnetic metall-carbon nanoparticles suitable for diagnostic and analytical target using nmr-relaxometry as a detection method
CN109954168B (en) * 2019-04-11 2021-08-27 江西理工大学 Uniformly and rapidly degradable iron-nano hydroxyapatite medical material and preparation method thereof
JP2021017373A (en) * 2019-07-17 2021-02-15 中國南玻集團股▲ふん▼有限公司 Self-cleaning agent for glass, self-cleaning glass, and manufacturing method and application thereof
WO2021019575A1 (en) * 2019-08-01 2021-02-04 Indian Institute Of Science A method for locomotion of a nanorobot and implementations thereof
CN110340348B (en) * 2019-08-05 2021-12-21 郴州市金贵银业股份有限公司 Nano silver powder, preparation method, silver paste and application
CN110584583A (en) * 2019-08-30 2019-12-20 常州延顺光电科技有限公司 Insertion tube assembly of ureteroscope
CN110483709B (en) * 2019-08-30 2021-09-14 陕西师范大学 Responsive crosslinked polymer micelle based on multiple hydrogen bond interaction, and preparation method and application thereof
KR102297995B1 (en) * 2019-10-24 2021-09-02 포항공과대학교 산학협력단 Iron oxide nanocube with open-mouthed cavity and methods for preparing the same
CN111493973B (en) * 2020-04-26 2021-04-23 北京纳米能源与系统研究所 Preparation method and assembly method of miniature magnetic control robot, inner core and thin film
CN112007754B (en) * 2020-08-27 2022-11-11 合肥维信诺科技有限公司 Pickup device
US11903666B2 (en) 2020-11-20 2024-02-20 The Board Of Trustees Of The Leland Stanford Junior University Magnetic wire for retrieval and elimination of calculus from the urinary tract
CN113281573A (en) * 2021-05-21 2021-08-20 哈尔滨理工大学 Method for testing electromagnetic performance of nano ferroferric oxide
KR102634542B1 (en) * 2021-06-15 2024-02-07 전남대학교 산학협력단 Method for manufacturing surface-modified magnetic nanoparticles and surface-modified magnetic nanoparticles manufactured therefrom
CN113604293B (en) * 2021-08-31 2023-07-11 浙江雅澜洗涤有限公司 Composite cleaning agent and preparation method thereof
EP4144308A1 (en) 2021-09-07 2023-03-08 Srinivasan, Shyam Magnetic device and system for urinary stone extraction using magnet
KR102596635B1 (en) * 2021-11-09 2023-11-02 한국전자기술연구원 Method for surface modification of nanoparticles to be hydrophobic
CN114522277B (en) * 2022-01-11 2022-11-18 广州医科大学附属第五医院 Design synthesis of in-situ gel and application of in-situ gel in medicament for removing calculus and fragments
CN114644823B (en) * 2022-03-09 2023-04-25 中国科学院化学研究所 PH responsive composite Janus nano-particle and preparation method thereof
WO2023229438A1 (en) * 2022-05-26 2023-11-30 포항공과대학교 산학협력단 Microfluidic reactor for producing microcapsules and external stimuli-responsive microcapsules produced by using same
CN115090275A (en) * 2022-06-10 2022-09-23 南京工业大学 Nano composite material for sewage treatment and application thereof
CN115337411A (en) * 2022-08-15 2022-11-15 广东省人民医院 TPGS-modified multifunctional magnetic nanoparticle and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090136594A1 (en) * 2007-11-27 2009-05-28 Board Of Regents, The University Of Texas System Functionalization of Micro-And Nano Particles for Selective Attachment to Calcium Biomineral Surfaces

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5582884A (en) * 1978-12-19 1980-06-21 Olympus Optical Co Flexible tube and its manufacture
US4240410A (en) 1979-01-23 1980-12-23 Storz Instrument Company Ophthalmic electromagnet
CN87100846A (en) * 1987-02-11 1988-08-24 刘孟陶 Magnetic bead and process thereof
CN87206141U (en) 1987-04-04 1988-01-27 刘跃武 Multifunction physicotherapy granula
US4802461A (en) * 1987-08-26 1989-02-07 Candela Laser Corporation Rigid endoscope with flexible tip
CN2031656U (en) * 1988-05-26 1989-02-01 中国人民解放军第一○七医院 Appliance for removing magnetic foreign bodies from eye
CN2043493U (en) * 1989-03-07 1989-08-30 李昭 Calculus-removing and calculus-smashing apparatus for cholelithiasis
US5364404A (en) 1990-12-21 1994-11-15 Cook Incorporated Neodymium-based magnetic retrieval catheter
US5228453A (en) * 1991-05-07 1993-07-20 Target Therapeutics, Inc. Catheter guide wire
JP3233953B2 (en) 1991-08-07 2001-12-04 オリンパス光学工業株式会社 Catheter device
US5357961A (en) * 1993-05-12 1994-10-25 Hdc Corporation Catheter guidewire and flushing apparatus and method of insertion
CN1098896A (en) * 1994-05-25 1995-02-22 营口市磁应用设备厂 Strong magnetic foreign matter sucker
US5682894A (en) * 1996-04-26 1997-11-04 Orr; Gregory C. Guide wire
US7066924B1 (en) * 1997-11-12 2006-06-27 Stereotaxis, Inc. Method of and apparatus for navigating medical devices in body lumens by a guide wire with a magnetic tip
US6157853A (en) * 1997-11-12 2000-12-05 Stereotaxis, Inc. Method and apparatus using shaped field of repositionable magnet to guide implant
JP3075355B2 (en) * 1998-02-05 2000-08-14 オリンパス光学工業株式会社 Basket type grasping forceps
US20080140101A1 (en) * 2006-12-07 2008-06-12 Revascular Therapeutic, Inc. Apparatus for crossing occlusions or stenoses
US6902528B1 (en) * 1999-04-14 2005-06-07 Stereotaxis, Inc. Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
US7527622B2 (en) * 1999-08-23 2009-05-05 Cryocath Technologies Inc. Endovascular cryotreatment catheter
US7772786B2 (en) * 1999-12-02 2010-08-10 Olympus Corporation Battery-powered light source device for endoscope
AU2001296217A1 (en) * 2000-07-24 2002-02-05 Stereotaxis, Inc. Magnetically navigated pacing leads, and methods for delivering medical devices
CN1152055C (en) * 2001-03-20 2004-06-02 清华大学 Surface cladding and radical functino modification method of magnetic microsphere, thus obtained microsphere and its application
CN1122674C (en) * 2001-07-16 2003-10-01 复旦大学 nm Microsphere of magnetic polymer and its preparing process
DE10201066B4 (en) * 2002-01-14 2004-07-15 Siemens Ag Shockwave source
JP2004043802A (en) 2002-06-14 2004-02-12 Rohm & Haas Co Polymer nanoparticle composition and its use for microorganism repellent coating
US7682366B2 (en) * 2002-10-16 2010-03-23 Olympus Corporation Calculus manipulation apparatus
JP4156898B2 (en) 2002-10-16 2008-09-24 オリンパス株式会社 Treatment fixture
US6875220B2 (en) 2002-12-30 2005-04-05 Cybersonics, Inc. Dual probe
GB2406276A (en) 2003-09-23 2005-03-30 Martin Lister Magnetic surgical instrument
JP4326003B2 (en) 2003-09-26 2009-09-02 株式会社日本触媒 Method for producing polymer-coated particles
US7533170B2 (en) 2005-01-06 2009-05-12 International Business Machines Corporation Coordinating the monitoring, management, and prediction of unintended changes within a grid environment
CN2933285Y (en) * 2005-04-06 2007-08-15 长沙天海分析检测自动化有限公司 Cleaning pick-up device for steel particles
CN102159143A (en) * 2006-09-29 2011-08-17 普拉罗美德公司 Methods for preventing retropulsion of concretions and fragments during lithotripsy
CN200987697Y (en) * 2006-12-26 2007-12-12 张家安 Humanbody hollow viscus metal foreign body extractor
US8597630B2 (en) 2007-04-19 2013-12-03 University Of Massachusetts Thermal-responsive polymer networks, compositions, and methods and applications related thereto
US9547415B2 (en) * 2007-04-30 2017-01-17 Oracle International Corporation Suite-wide navigation
US20090041673A1 (en) * 2007-08-03 2009-02-12 Anygen Co., Ltd. Thermally Crosslinked Contrast Agents
CN100575376C (en) * 2007-10-26 2009-12-30 中山大学 A kind of magnetic temperature sensing nano-particle and synthetic method thereof with biocompatibility
JP5371228B2 (en) 2007-11-08 2013-12-18 オリンパス株式会社 Endoscopic treatment tool
CN201108459Y (en) 2007-11-20 2008-09-03 张伟 Lead wire aspirator for knee joint lens operation
US20110006245A1 (en) * 2007-12-04 2011-01-13 Hiroshi Handa Polymer coated inorganic fine particle and method for preparing the same
IL188067A (en) * 2007-12-12 2011-12-29 Lithotech Medical Ltd Device for fragmenting and removing concretions from body ducts and cavities
HU230862B1 (en) 2008-04-28 2018-10-29 DARHOLDING Vagyonkezelő Kft Device and method for continuous production of nanoparticles
CN201323106Y (en) * 2008-10-31 2009-10-07 李维跃 Variable reluctance iron attracting tool
US20110028785A1 (en) * 2009-07-31 2011-02-03 There In One Enterprises Co., Ltd. Endoscope with adjustable viewing angle
WO2011062217A1 (en) 2009-11-20 2011-05-26 戸田工業株式会社 Magnetic iron oxide microparticle powder, aqueous dispersion containing magnetic particles, and process for production of same
WO2012071473A2 (en) 2010-11-24 2012-05-31 Mount Sinai School Of Medicine Magnetic based device for retrieving a misplaced article
CN202020521U (en) 2011-03-28 2011-11-02 郭先科 Endoscope snare for fetching foreign matters
CN202020520U (en) 2011-03-28 2011-11-02 郭先科 Endoscope reticular basket for removing foreign bodies
CN202051675U (en) * 2011-03-30 2011-11-30 郑飞 Movable magnetic mop
CN202096279U (en) 2011-04-02 2012-01-04 河南理工大学 Foreign matter taking forceps with endoscope
CN202096278U (en) 2011-04-02 2012-01-04 河南理工大学 Foreign body taking hook of endoscope
KR101309360B1 (en) * 2011-07-15 2013-09-17 단국대학교 산학협력단 Nanocomposites comprising with calcium phosphate adsorbed modified carbon nanotubes and degradable polymer and method of preparing thereof
CN102429703A (en) * 2011-09-02 2012-05-02 王宝根 Pneumatically-controlled stone extractor with magnet
US20130197297A1 (en) * 2012-01-27 2013-08-01 Kurt J. Tekulve Magnetic clot disrupter
JP6174603B2 (en) 2012-01-27 2017-08-02 ソルシオネス ナノテクノロジカス,エス.エル.Soluciones Nanotecnologicas,S.L. Contrast agent for T2 * -weighted magnetic resonance imaging (MRI)
CA2881685C (en) 2012-08-14 2023-12-05 10X Genomics, Inc. Microcapsule compositions and methods
CN103111614B (en) * 2013-02-05 2015-02-25 西安金磁纳米生物技术有限公司 Manufacturing method of gold magnetic nanoparticles of surface modification functional perssad
RU2516961C1 (en) 2013-02-11 2014-05-20 Федеральное государственное бюджетное учреждение науки Институт прикладной механики Российской академии наук (ИПРИМ РАН) Magnetically controlled sorbent for endo- and exotoxin elimination in humans
US8690907B1 (en) * 2013-03-15 2014-04-08 Insera Therapeutics, Inc. Vascular treatment methods
EP2796101B1 (en) 2013-04-23 2016-04-20 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kit for producing a cross-linked gel for encapsulating kidney stones and/or kidney stone fragments
CN203208098U (en) 2013-04-25 2013-09-25 郝波 Device for gripping ferrous metal foreign body under gastroscope
CN103242494B (en) * 2013-05-27 2016-02-10 上海交通大学 The preparation method of the composite microgel of the triple susceptibility in a kind of temperature, pH and magnetic field
WO2014194102A1 (en) 2013-05-29 2014-12-04 Stayton Patrick S Stimuli-responsive magnetic nanoparticles
CN103386135B (en) * 2013-07-24 2015-05-20 上海交通大学 Preparation method of multifunctional medicine carrier integrating magnetism, fluorescence and thermosensitivity
CN103536935B (en) * 2013-11-26 2015-09-09 上海师范大学 Core-shell structure magnetic nano composite material that a kind of photosensitizer is modified and its preparation method and application
CN103861729B (en) * 2014-02-27 2016-08-31 中铝广西有色金源稀土股份有限公司 A kind of easy device collecting magnetic
KR20150104901A (en) 2014-03-07 2015-09-16 비손메디칼 주식회사 Laser apparatus for medical treatment
CN104448088B (en) * 2014-11-03 2017-02-15 西北工业大学 Preparation method of temperature-sensitive anisotropic magnetic microcapsule
CN104382635B (en) * 2014-11-28 2016-10-26 中国人民解放军第二军医大学 A kind of foreign body in bladder extractor
CN104622845A (en) * 2015-01-02 2015-05-20 吉林大学 Preparation method of chitosan microcapsules containing magnetic nano particles inside
CN104914243A (en) * 2015-05-25 2015-09-16 苏州万纳生物科技有限公司 Magnetic nanoparticle biological probe, preparation method and application thereof
CN106552296B (en) 2015-09-29 2020-08-14 上海氪励铵勤科技发展有限公司 Nano particles, preparation method thereof, calculus removing device and application
GB201520959D0 (en) 2015-11-27 2016-01-13 Astrazeneca Ab And Cancer Res Technology Ltd Bis-pyridazine compounds and their use in treating cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090136594A1 (en) * 2007-11-27 2009-05-28 Board Of Regents, The University Of Texas System Functionalization of Micro-And Nano Particles for Selective Attachment to Calcium Biomineral Surfaces

Also Published As

Publication number Publication date
CN106552296A (en) 2017-04-05
JP2019501189A (en) 2019-01-17
JP2018532526A (en) 2018-11-08
CN107921181A (en) 2018-04-17
CN108348283A (en) 2018-07-31
EP3357521A4 (en) 2019-06-19
EP3348287A1 (en) 2018-07-18
CN108025115B (en) 2021-04-20
WO2017054750A1 (en) 2017-04-06
RU2694471C1 (en) 2019-07-15
EP3348287A4 (en) 2019-03-27
US20180271609A1 (en) 2018-09-27
WO2017054753A1 (en) 2017-04-06
CN108025115A (en) 2018-05-11
KR20180063192A (en) 2018-06-11
WO2017054749A1 (en) 2017-04-06
JP6669876B2 (en) 2020-03-18
RU2727236C1 (en) 2020-07-21
EP3348215A1 (en) 2018-07-18
JP2018531126A (en) 2018-10-25
US11331417B2 (en) 2022-05-17
JP6719565B2 (en) 2020-07-08
US20180280039A1 (en) 2018-10-04
RU2723259C1 (en) 2020-06-09
KR102164560B1 (en) 2020-10-12
KR20180063197A (en) 2018-06-11
CN106552296B (en) 2020-08-14
KR20180063198A (en) 2018-06-11
EP3357521A1 (en) 2018-08-08
EP3348215A4 (en) 2019-06-19
KR102112744B1 (en) 2020-05-19
CN107921181B (en) 2021-01-12
KR102169606B1 (en) 2020-10-23

Similar Documents

Publication Publication Date Title
US20180289866A1 (en) Nanoparticles and preparation method thereof
JP2018531126A6 (en) Magnetic target separation instrument and use
RU2541538C1 (en) Biocompatible agent for dispersing nanoparticles in water medium with application of polymer imitating adhesive protein of mussel
Roy et al. Stimuli-responsive poly (N-isopropyl acrylamide)-co-tyrosine@ gadolinium: Iron oxide nanoparticle-based nanotheranostic for cancer diagnosis and treatment
CN104151764B (en) A kind of magnetic composite microsphere of polymer brush modification and preparation method and application
KR20160145991A (en) Magnetic nano composite and preparation method thereof
Zasonska et al. The use of hydrophilic poly (N, N-dimethylacrylamide) for promoting engulfment of magnetic γ-Fe2O3 nanoparticles by mammalian cells
EP2647391B1 (en) Mri contrast agent containing composite particles
CN110237048B (en) PEG-modified magnetic/quaternized chitosan nanoparticles with peroxidase activity and preparation method and application thereof
Saengruengrit et al. Effective gene delivery into primary dendritic cells using synthesized PDMAEMA-iron oxide nanocubes
Alieva et al. Magnet-induced behavior of iron carbide (Fe7C3@ C) nanoparticles in the cytoplasm of living cells
CN105778020B (en) A kind of preparation method of water-soluble iron magnetic nanometer
Karimi et al. 3-(Propylcarbamoyl) acrylic Acid Functionalized Magnetic Nanoparticles Grafted to Poly (N-isopropylacrylamide-co-Acrylic Acid) Hydrogel: LCST and Drug Release
TWI462746B (en) Preparation of poly(ethylene glycol)-b-poly-(ε-caprolactone)-poly(acrylic acid) and its applications
Zasonska et al. The Use of Hydrophilic Poly (N, N-dimethylacrylamide) for Promoting Engulfment of Magnetic-Fe 2 O 3 Nanoparticles by Mammalian Cells
CN101648025A (en) Method for preparing magnetic nano contrast agent and application thereof in pancreatic cancer magnetic resonance imaging

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHANGHAI CLINICAL ENGINE TECHNOLOGY DEVELOPMENT CO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SUN, YINGHAO;REEL/FRAME:047003/0862

Effective date: 20180709

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION